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In vitro Synthese ist eine biotechnologische Alternative zu klassischen chemischen Katalysen.
Der manuelle Entwurf von mehrstufigen Biosynthesewegen ist jedoch sehr anspruchsvoll,
vor allem wenn Enzyme verschiedener Organismen beteiligt sind. Daher besteht ein Bedarf
an Methoden, die helfen solche Synthesewege in silico zu entwerfen und die in der Lage
sind große Mengen biologischer Daten zu bewältigen - insbesondere in Hinblick auf die
Rekonstruktion genomskaliger metabolischer Netzwerkmodelle und die Pfadsuche in solchen
Netzwerken.
In dieser Arbeit wird ein Algorithmus zur Pfadsuche zu einem Zielprodukt ausgehend von
beliebigen Substraten präsentiert. Der Algorithmus basiert auf einem gemischt-ganzzahligen
linearen Programm, das Graphtopologie mit Reaktionsstöchiometrien kombiniert. Die Pfad-
kandidaten werden anhand verschiedener Kriterien geordnet, um die am besten geeigneten
Kandidaten für die Synthese zu finden. Außerdem wird ein umfassender Workflow für die
Rekonstruktion metabolischer Netzwerke basierend auf der Datenbank KEGG sowie thermody-
namischen Daten vorgestellt. Dieser umfasst einen Filter, der anhand verschiedener Kriterien
geeignete Reaktionen auswählt. Der Workflow wird zum Erstellen einer organismusüber-
greifenden Netzwerkrekonstruktion, sowie Netzwerken einzelner Organismen genutzt. Diese
Modelle werden mit graphentheoretischen Methoden analysiert. Es wird diskutiert, wie die
Ergebnisse für die Planung von biosynthetischen Produktionswegen genutzt werden können.
Abstract
In vitro synthesis is a biotechnological alternative to classic chemical catalysts. However, the
manual design of multi-step biosynthesis routes is very challenging, especially when enzymes
from different organisms are involved. There is therefore a demand for in silico tools to
guide the design of such synthesis routes using computational methods for the path-finding,
as well as the reconstruction of suitable genome-scale metabolic networks that are able to
harness the growing amount of biological data available.
This work presents an algorithm for finding pathways from arbitrary metabolites to a target
product of interest. The algorithm is based on a mixed-integer linear program (MILP)
and combines graph topology and reaction stoichiometry. The pathway candidates are
ranked using different ranking criteria to help finding the best suited synthesis pathway
candidates. Additionally, a comprehensive workflow for the reconstruction of metabolic
networks based on data of the Kyoto Encyclopedia of Genes and Genomes (KEGG) combined
with thermodynamic data for the determination of reaction directions is presented. The
workflow comprises a filtering scheme to remove unsuitable data. With this workflow, a pan-
organism network reconstruction as well as single organism network models are established.
These models are analyzed with graph-theoretical methods. It is also discussed how the
results can be used for the planning of biosynthetic production pathways.
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The following chapter is based on the published review article
HEINZLE, E., WEYLER, C., KRAUSER, S., & BLASS, L. K. (2013): Directed
multistep biocatalysis using tailored permeabilized cells. A.-P. ZENG (Ed.),
Advances in biochemical engineering/biotechnology (pp. 185–234). Springer
Berlin Heidelberg. https://doi.org/10.1007/10_2013_240
that I co-authored.
In billions of evolutionary steps, nature developed an impressive set of strategies to create
molecules with a wide range of structures. Nearly every carbon-, nitrogen-, oxygen-, or
sulfur-containing skeleton and functional group can be assembled in principle by bioconver-
sions. A large number of different enzymatically catalyzed reactions support cellular growth
and survival (LOPEZ-GALLEGO et al., 2010). Not only the substrate and reaction specificity
but also the efficiency of enzymatic reactions are usually far beyond man-made chemical
processes. Recent developments in biochemical research not only support a detailed mecha-
nistic understanding of relationship of structure and reactivity, but they also allow extended
targeted redesign and modification of enzymes. Even completely new functionalities can be
designed and created with modern molecular and modeling tools (e.g. Diels-Alder synthesis
with a de novo designed enzyme (SIEGEL et al., 2010)). The development and present status
concerning biocatalysis - mostly based on engineered single enzymes - have been reviewed
thoroughly elsewhere (BORNSCHEUER et al., 2012). Recent developments in the field of
metabolic network research, both experimentally as well as computationally, open up new
potentials for multi-step biocatalysis both in vivo as well as in vitro.
3
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Presently, slightly more than 100 commercial applications use enzymes in industrial-scale
processes (LIESE et al., 2000). Due to the usually high price, the time required for improving
enzymes genetically, the often shorter development times required for organic chemistry
alternatives, and the still widespread ignorance of biocatalysis in the field of organic chemistry,
bioconversion processes are often not considered (WOHLGEMUTH, 2011). There is, however,
a trend towards biotechnological processes as the ecological impact (E-factor) of industrial
productions is gaining weight and public pressure demands a sustainable industry (AEHLE,
2004; DRAUZ et al., 2012; HEINZLE et al., 2006; WOHLGEMUTH, 2010). Biocatalytic processes
often have a very low ecological impact, such as with selective oxidation of carbohydrates
(SCHNEIDER et al., 2012), but in some cases chemical alternatives are similar or even better
(KUHN et al., 2010).
Although in vivo synthesis using whole, viable microorganisms provides complex products
from simple and cheap raw materials by fermentation, it is limited by the fitness and tolerance
of the organism and by cellular transport processes. Modern metabolic engineering methods
provide a whole toolbox comprising computational and molecular tools for directed design
and optimization of production pathways. In most cases, these allow the conversion of a
poorly producing native organism into a highly efficient producer strain. However, transport
barriers, bottlenecks in the metabolism, toxic side effects, and the usually required complex
downstream processing of resulting mixtures of product and growth medium limit the
industrial applications (Figure 1.1, Case C).
In vitro synthesis, on the other hand, serves as a biotechnological alternative to the classic
chemical catalysts. Engineered for the highest activity, stability, and substrate spectrum,
enzymes provide the highest turnover rates, simultaneously working with outstanding selec-
tivity (BORNSCHEUER et al., 2012). However, in case of complex syntheses, the use of enzymes
is restricted by required optimal conditions for each enzyme and potential intermediate
clean-up or buffer change between individual steps (Figure 1.1, Case A). Additionally, the re-
generation of cofactors, such as nicotinamide adenine dinucleotide (phosphate) (NAD(P)H),
limits this type of application.
A further alternative is the one-pot synthesis using multiple enzymes; however, they require
extended optimization of enzymes to operate at the same pH and buffer concentrations
(Figure 1.1, Case B). This approach can also be taken using cell hydrolysates of suitable
strains, as has been reviewed elsewhere (YOU et al., 2013). On the other hand, various
approaches use synthetic assemblies of enzymes, such as in emulsions, using scaffolds,
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Figure 1.1: Types of multi-step biosynthetic processes. A: Synthesis using multiple enzymes in
separate processes, B: Synthesis with all enzymes reacting in one-pot, C: In vivo synthesis using
living cells in fermentation processes, D: In situ synthesis using permeabilized cells.
tethering to surfaces, or covalent binding to achieve one-pot synthesis biocatalysis (MOSES
et al., 2013).
Yet another strategy uses permeabilized cells - often called in situ synthesis (Figure 1.1,
Case D). Permeabilized cell membranes allow diffusion of small compounds between the
intracellular space and the surrounding reaction buffer while large biopolymers (i.e. proteins
and deoxyribonucleic acid (DNA)) remain trapped inside the microenvironment of the cell.
Contrary to using cell hydrolysates, which has a very long tradition (YOU et al., 2013),
optimal permeabilization will keep the enzymes in their native macromolecular environment
and does not cause any denaturation of enzymes by the permeabilizing agent. In this
way, the macromolecular crowding effects that are expected to modify protein activities
(MINTON, 2006), such as channeling (MONTI et al., 2009), are preserved in their original
status. Removing all small metabolites and cofactors represents a kind of reset of the
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metabolic network, permitting directed conversions by the selection of appropriate substrate
combinations. In general, this can be combined with careful tailoring of the enzymatic outfit of
a cell, thus increasing selectivity of bioconversion using permeabilized cells. Network changes
may involve gene deletions, gene amplification, or heterologous gene expression. Additionally,
selective inhibitors might be used to block undesired side reactions (KRAUSER et al., 2012). An
interesting alternative concept (YE et al., 2012) uses enzymes from thermophilic organisms
that are expressed in a mesophilic organism. Cells are cultivated and then heated to rupture
the cells and inactivate enzymes that are not desired for the in vitro biocatalytic conversion.
The term ‘in situ synthesis’ was introduced in the early 1960s, indicating that macromolecules
remain in their original macromolecular environment. Prokaryotic and eukaryotic cells can
be permeabilized, but the permeabilization procedure depends on the composition of the cell
wall and has to be optimized for each cell type. Early studies on permeabilized cells by Felix
showed promising results. Felix concluded that permeabilized cells can be produced quickly
and simply and can be used several times, thus requiring less energy for the synthesis of
biomass (FELIX, 1982). These studies on synthesis with permeabilized cells never achieved
appropriate acknowledgment, however - likely because of the missing genetic and metabolic
engineering tools at that time. The available tools have dramatically changed since then, and
it seems obvious that synthesis with permeabilized cells will provide an alternative method,
thus closing the gap between in vivo and in vitro biosynthesis.
The enormous increase in DNA sequencing power has recently created an overwhelming
wealth of genome and metabolic network information of a large number of single (micro)or-
ganisms but also of microbial habitats using metagenome analysis. In parallel, computational
tools for handling and exploring this vast amount of data have been developed at a high
rate. However, detailed biochemical knowledge of enzyme characteristics is lagging far
behind. Nevertheless, genome and enzyme databases provide an enormous amount of data
that may be explored for permeabilized cell synthesis. Whole genome metabolic networks
become increasingly available - a few of them already carefully curated. Metabolic regu-
lation is also increasingly explored, but it requires considerably higher effort compared to
sequencing. For some microorganisms, such as Escherichia coli and Saccharomyces cerevisiae,
metabolic and regulatory networks are already fairly well understood, but we are still quite
far away from the comprehensive understanding required for creating fully predictive models.
This is even more the case or the majority of microorganisms. The metabolism of microor-
ganisms may differ considerably. Nevertheless, they all share large parts of their central
metabolism, particularly the 12 small precursor molecules representing the bottleneck of the
bow-tie-shaped structure of metabolic networks (MA et al., 2003). These precursor molecules
7
serve as starting materials for all building blocks and polymers that can be synthesized in
the metabolic network (Figure 1.2). Biopolymers constitute the major fraction of cellular
Figure 1.2: Overall structure of metabolism
biomass. Secondary metabolites are of great interest as pharmaceutically active compounds
or precursors thereof. These are synthesized starting from precursor metabolites and building
blocks. Up to now, this has in most cases been done with fully intact genetically engineered
cells.
With the present knowledge, molecular and computational methods, and the advent of new
possibilities of designing and engineering enzymes and whole metabolic pathways, a large
field of applications opens up. Together with the long-known technique of permeabilization
of cellular barriers (i.e. cell membranes and cell walls), new and intriguing opportunities for
designing tailored biocatalyst and bioprocesses become accessible. Once such a biocatalyst is
established, it can be produced easily by simple cultivation followed by permeabilization.
Downstream processing would simply start with the removal of the biocatalyst, such as by
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centrifugation. There are, however, major hurdles to be overcome as far as more complex
biosynthesis is concerned. The most important are the supply of precursors and cosubstrates,
such as adenosine 5’-triphosphate (ATP) or NAD(P)H; the achievement of selective biocat-
alysts, meaning the elimination of the manifold possible undesirable side reactions; and
the intensification of processes to obtain high final product concentrations. To reach these
goals, it is important to understand (i) the permeabilization process on a molecular basis,
(ii) biosynthetic pathways and their regulation, (iii) supply of precursor molecules, (iv)
regeneration of cosubstrates, (v) design and selection of enzymes as part of the biosynthetic
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Directed, selective biosynthesis using either cell hydrolysates or permeabilized cells can be
a straightforward process for shorter paths or small networks. It is, however, becoming
increasingly challenging for longer biosynthetic paths with more compounds involved. The
number of potentially undesired side reactions increases dramatically. Therefore, there is a
great need to guide the design of such complex biocatalysts by using adequate computational
tools and the rapidly increasing information available on mostly public databases. Panke
and Bujara proposed an in silico tool for network topology analysis based on genome-scale
metabolic network models to be applied for in vitro biocatalysis in cell-free systems (BUJARA
et al., 2012). Starting out from the whole-genome scale metabolic reconstruction of E. coli
(FEIST et al., 2007), they introduced several changes, particularly concerning transport and
other membrane processes. Considering basic thermodynamic data and expression data from
E. coli, they arrived at a model that could eventually predict interfering pathways for the
production of dihydroxyacetone phosphate starting from glucose. The presently available
examples of pathway prediction for biosynthesis using either cell extracts or permeabilized
9
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cells are still very limited, but we expect that there will be a rapid increase of such studies in
the very near future. There is, however, a whole series of studies available for living cells
that are separated from the environment by their envelopes, providing selective transport of
molecules in and out of the cells.
Modern planning and development of biochemical syntheses or novel synthesis routes in
living organisms is effectively supported by the use of appropriate in silico tools. Such
tools are increasingly available for pathway design in microorganisms and allow quick and
directed engineering of living cells (KROEMER et al., 2006; NEUNER et al., 2011). These tools
rely heavily on the existence and quality of the numerous biological databases containing
information on different aspects such as genome sequences, enzyme data, or even whole
pathways (Tables 2.1 to 2.5). Together with data from primary literature and further sources,
this information can be used for the composition of network reconstructions of the organism
of interest. Such networks can then be conveniently analyzed and developed further with
different bioinformatic tools (Table 2.7 later in Section 2.2 Bioinformatic Tools). In particular,
they can be used to design pathways or biosynthetic subnetworks useful for biocatalytic
purposes, such as the in situ synthesis of a desired primary or secondary metabolite. With
an increasing number of steps and increasing numbers of metabolites and coenzymes, the
involved design becomes an increasingly complex task.
2.1 Databases
Biological databases can be classified into several different categories, such as biochemical
databases, genome databases, protein or enzyme databases, pathway databases, or model
databases (Tables 2.1 to 2.5). This classification is based on the biological content of the
respective databases. However, an overlap of information can occur. For example, genome
databases (Table 2.2) also contain protein sequence information.
Biochemical Databases
Table 2.1 lists different biochemical databases. Rhea (MORGAT et al., 2016) is a manually
annotated, expert-curated reaction database with a main focus on enzyme-catalyzed reactions.
It also contains other types of reactions. All reaction participants are linked to Chemical
Entities of Biological Interest (ChEBI) (HASTINGS et al., 2015), which provides data such
as structure, formula, and charge. All reactions in the database are stoichiometrically and
charge-balanced and reaction directionality is added if it is available.
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Table 2.1: Biochemical databases
Database URL Content
PubChem (S. Kim et al.,
2019)
http://pubchem.ncbi.nlm.nih.gov Chemical molecules and
their activities against bio-
logical assays
ChEBI (Hastings et al.,
2015)
http://www.ebi.ac.uk/chebi Chemical Entities Of Bio-
logical Interest
TCDB (Saier Jr et al., 2015) http://www.tcdb.org Transporter Classification
Database
Transport DB (Elbourne et
al., 2016)
http://www.membranetransport.org Transporter protein analy-
sis database
SABIO-RK (Wittig et al.,
2012)
http://sabio.villa-bosch.de Biochemical reaction ki-
netics
Rhea (Morgat et al., 2016) http://www.ebi.ac.uk/rhea Manually annotated
database of chemical
reactions
MINE (Jeffryes et al.,
2015)
https://minedatabase.mcs.anl.gov Metabolic In Silico
Network Expansion
Databases
SABIO-RK (WITTIG et al., 2012), the biochemical reaction kinetics database, is a curated
database containing biochemical reactions and their corresponding kinetics. It describes the
participants and modifiers of the reactions as well as measured kinetic data, such as kinetic
rate equations, embedded in an experimental and environmental context.
The Transporter Classification Database (TCDB) (SAIER JR et al., 2015) provides a functional
and phylogenetic classification of membrane transport proteins. The classification system
used is the transporter classification (TC) system that is analogous to the Enzyme Commission
(EC) number for enzymes. The database is curated with data from over 15,000 published
references. It contains over 18,000 unique protein sequences that are classified in more than
1,600 transporter families.
TransportDB (ELBOURNE et al., 2016) contains the predicted cell membrane transport protein
complement for over 2760 organisms (bacteria, archaea, and eukaryota). The protein
classification is done according to the TC classification system.
MINE (JEFFRYES et al., 2015) is a database containing predicted molecules that are likely
to occur in reactions based on known metabolites and common biochemical reactions. The
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prediction utilizes BNICE (HATZIMANIKATIS et al., 2005) and expert-curated reaction rules.
The database contains more than 571,000 compounds.
ATLAS of Biochemistry (HADADI et al., 2016) is a database containing all possible theoretical
biochemical reactions (more than 137,416 known and novel reactions) predicted with BNICE
(HATZIMANIKATIS et al., 2005) using the means of enzyme reaction rules as well as other
cheminformatic tools.
Genome Databases
Genome databases (Table 2.2) contain nucleotide sequences and functional annotations.
GenBank (BENSON et al., 2013), run by the National Center for Biotechnology Information
(NCBI), is a genetic sequence database of all publicly available DNA sequences. It contains
the bibliographic and biological annotated sequences from almost 260,000 organisms. NCBI
Entrez Gene (MAGLOTT et al., 2011) is a gene database containing a large variety of infor-
mation that focuses on completely sequenced genomes. NCBI Entrez Genome (SAYERS et al.,
2012) contains sequence and map data of more than 1,000 species or strains. The Gene
Ontology (GO) (ASHBURNER et al., 2000; T. G. O. CONSORTIUM, 2019) focuses on the function
genes.





of all publicly avail-
able DNA sequences
NCBI Entrez Genome
(Sayers et al., 2012)






(Maglott et al., 2011)
http://www.ncbi.nlm.nih.gov/gene Database of genes
GO (Ashburner et al.,
2000; T. G. O. Consor-
tium, 2019)
http://www.geneontology.org The Gene Ontology





Protein and Enzyme Databases
Protein and enzyme databases (Table 2.3) collect functional information from proteins and
enzymes. Braunschweig Enzyme Database (BRENDA) (JESKE et al., 2018), is a collection of
Table 2.3: Protein and enzyme databases
Database URL Content
BRENDA (Jeske et al.,
2018)








http://www.uniprot.org The Universal Protein Re-
source
PSORTdb (Peabody et al.,
2016; Yu et al., 2011)
http://db.psort.org Protein subcellular localiza-
tions for bacteria and ar-
chaea
ProLinks (Bowers et al.,
2004)
http://prl.mbi.ucla.edu/prlbeta Inferring functional link-
ages between proteins
STRING (Szklarczyk et al.,
2019)
http://string-db.org Search Tool for the Re-
trieval of Interacting
Genes/Proteins




functional and property data of enzymes. The majority of the contained data is manually
extracted from primary literature and covers information in over 50 data fields, such as
classification and nomenclature; reaction and specificity; information on function, struc-
ture, occurrence, preparation, and application of enzymes; and properties of mutants and
engineered variants. Enzymes in BRENDA are linked to their respective pathways, source
organism, and protein sequence, if deposited.
UniProt (U. CONSORTIUM, 2018), the universal protein resource, contains information on
protein sequences and annotation data. It comprises four databases, namely the UniProt
Knowledgebase (UniProtKB), the UniProt Reference Clusters (UniRef), the UniProt Archive
(UniParc), and the UniProtMetagenomic and Environmental Sequences (UniMES) database
on metagenomic and environmental data. UniProtKB is a collection of functional information
on proteins together with annotation. The core data available for each protein are its
amino acid sequence, protein name or description, taxonomic data, and citation information.
Additionally, it contains as much annotation information as possible, such as ontologies,
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classifications, and cross-references, together with an indication of annotation quality. The
database consists of two sections: UniProtKB/SwissProt contains reviewed and manually
annotated records, whereas UniProtKB/TrEMBL has data records that are unreviewed and
automatically annotated and still await full manual annotation. In the April 2020 release,
UniProtKB/Swiss-Prot contained more than 562,000 sequence entries and UniProtKB/TrEMBL
contained more than 180,690,000 sequence entries. UniRef is a database providing clustered
sets of sequences from UniProtKB, including splice variants and isoforms and selected
UniParc records. Its purpose is to obtain the complete coverage of sequence space at several
resolutions. UniParc contains most of the publicly available protein sequences.
The planning of a biochemical synthesis involves, besides other aspects, the determination of
possible side reactions. Those unwanted reactions may lead to a decrease in the yield of the
desired product and complicate the downstream processing. It would thus be favorable to find
information on all reactions catalyzed by the enzyme of interest including thermodynamic
and kinetic parameters. Some of the enzyme resources presented in Table 2.3 contain
information on single enzymes. However, as of 2020, there is, to our knowledge, no database
that presents such information in a systematic manner.
Model Databases
Model databases (Table 2.4) are repositories of mathematical models of biological systems.
They contain models ranging from reconstructions of individual pathways up to genome-scale
metabolic networks of organisms.
Table 2.4: Model databases
Database URL Content
BiGG (King, Lu, et al.,
2015)






BioModels (Chelliah et al.,
2014; Glont et al., 2017)
https://www.ebi.ac.uk/biomodels Annotated Published Mod-
els
EcoCyc (Keseler et al.,
2017)
http://ecocyc.org E. coli K-12 MG1655
SGD (Cherry et al., 2011) http://www.yeastgenome.org S. cerevisiae Genome
Database
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BiGG Models is a knowledge base of biochemically, genetically, and genomically structured
genome-scale metabolic network reconstructions (KING, LU, et al., 2015). As of Mai 2020,
it contains 108 different genome-scale reconstructions from different organisms and share
a standard nomenclature. BiGG allows browsing the model contents, the visualization of
metabolic pathway maps with the Escher pathway visualization library (KING, DRÄGER, et al.,
2015), as well as the export of all models into different standard formats.
BioModels (CHELLIAH et al., 2014; GLONT et al., 2017) is a repository for computational
models of biological systems. In August 2019, it contained more than 10,000 manually
curated, auto-generated or non-curated models. The database features browsing of models
through lists, based on GO terms or using the taxonomy annotations as well as model search.
The model presentation gives access to all information stored about a model. All models
can be exported in various file formats or represented graphically. Basic model simulation is
also possible. The functionality of BioModels can also be accessed by other software tools
through its web services.
Pathway Databases
Pathway databases (Table 2.5) contain data on biochemical pathways, their reactions, and
components that are involved in them and their corresponding interactions, thus describing
the biochemistry of metabolic processes. These databases offer the possibility of providing
several types of information in the context of graphical representation of the pathways in
pathway maps.
BioCyc (KARP et al., 2017) is a collection of more than 17,000 pathway/genome databases
in version 23.5. Each database contains the genome and metabolic pathways of a single
organism. Based on the quality of the data, the databases are divided into three tiers. Tier
1 contains databases that are curated based on literature data. Tier 2 and tier 3 databases
contain computationally predicted metabolic pathways, predictions as to which genes code for
missing enzymes in metabolic pathways, and predicted operons. Tier 2 undergoes moderate
curation and tier 3 is not curated at all.
The KEGG (KANEHISA et al., 2012; KANEHISA et al., 2018) is a curated database resource
that integrates genomic, chemical, and systemic function information of various organisms.
Its knowledge base consists of 18 main databases in the 5 categories systems information
(pathway, brite, module); genomic information (orthology, genome, genes, ssdb); chemical
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Table 2.5: Pathway databases
Database URL Content
KEGG (Kanehisa et al.,
2012; Kanehisa et al.,
2018)
http://www.genome.jp/kegg Kyoto Encyclopedia of
Genes and Genomes
BioCyc (Karp et al.,
2017)










ways (Artimo et al.,
2012)

















et al., 2017; Jassal et
al., 2019)
https://reactome.org Manually curated and
peer-reviewed path-
way database
information (compound, glycan, reaction, enzyme); health information (network, variant,
disease, drug, environ) and drug labels (medicus).
The BioPath database (REITZ et al., 2004) contains molecules, reactions, and biological
pathways. Its first version is based on the Roche Applied Science ’Biochemical Pathways’
wall chart and is extend with additional information from literature. In its version 3, BioPath
contained about 14,000 chemical structures and about 3,900 biochemical transformations.
A new version of the book form was also published (MICHAL et al., 2012).
The EAWAG-BBD contains information about microbial biocatalytic reactions and biodegra-
dation pathways for xenobiotic compounds (GAO et al., 2010). Information on microbial
enzyme-catalyzed reactions that are important for biotechnology can also be found. A Swiss
bioinformatics group has opened their database for automated model construction and
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genome annotation for large-scale metabolic networks, providing links to several hundred
genome-scale metabolic networks (GANTER et al., 2013).
The Reactome database (FABREGAT et al., 2017; JASSAL et al., 2019) is a manually curated,
peer-reviewed, open-source and open access pathway database. It contains information
on signaling and metabolic molecules. The database features pathway visualization, data
analysis tools as well as downloads of all data in major open-data standards such as Sys-
tems Biology Markup Language (SBML), Systems Biology Graphical Notation (SBGN) and
Biological Pathway Exchange (BioPax) (DEMIR et al., 2010).
Organism-Specific Databases
Information about specific organisms are often collected in organism-specific databases
(Table 2.6). Examples for such databases are EcoCyc (KESELER et al., 2017), which contains
E. coli K-12 MG1655 data, or the S. cerevisiae Genome Database SGD (CHERRY et al., 2011).
Table 2.6: Organism specific databases
Database URL Content
EcoCyc (Keseler et al., 2017) http://ecocyc.org E. coli K-12 MG1655
SGD (Cherry et al., 2011) http://www.yeastgenome.org S. cerevisiae Genome
Database
Summary
In this thesis, the data for the genome-scale metabolic network reconstructions and the
organism-specific network reconstructions is exclusively taken from KEGG. However, the
information contained in the databases listed in Tables 2.1 to 2.5 could additionally be
used to extend and enhance the networks. For organism-specific networks, especially the
information in the databases listed in Tables 2.4 and 2.6 are helpful. They already contain
models of numerous organisms, which can either be used with minimal changes or taken as
a basis for network reconstructions in combination with further resources.
2.2 Bioinformatic Tools
For the automated reconstruction of networks and analysis of network reconstructions,
various bioinformatic tools are available. A selection is listed in Table 2.7.
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scale metabolic models simu-




Genome Analysis and Discov-
ery System for the in silico
analysis of organisms
Analysis




MATLAB package for structural
and functional analysis of bio-
chemical networks












flux modes of metabolic net-
works






2.2 Bioinformatic Tools 19
Model SEED (OVERBEEK et al., 2005) is a web-based resource for the high-throughput genera-
tion, optimization, and analysis of genome-scale metabolic network models. It integrates and
augments technologies for the genome annotation, the construction of gene-protein reaction
associations, the generation of biomass reactions, reaction network assembly, thermodynamic
analysis of reaction reversibility, and model optimization to generate draft genome-scale
metabolic network models. The generation of a metabolic network reconstruction from the
assembled genome sequence takes about 48 h and automates nearly every step.
PathwayTools (KARP et al., 2015) is a software environment for the creation of pathway/genome
databases (PGDBs) such as EcoCyc (KESELER et al., 2017). It allows the prediction of
metabolic pathways and operons and network gap filling. Curators can interactively edit
PGDBs. A large number of query and visualization tools as well as tools for comparative
and systems biology analyses are available. Pathway Tools consists of three components.
PathoLogic is used to create new PGDBs from annotated genomes. The Pathway/Genome
Editors allow for the refinement of PGDBs. With the Pathway/Genome Navigator querying,
visualization and analyses of PGDBs can be carried out.
Metatool (von KAMP et al., 2006) is a user-friendly tool for the calculation of elementary
flux modes, conservation relations, and enzyme subsets in metabolic networks. Version 5.1
can be embedded into GNU Octave and MATLAB through script files and shared libraries.
For calculations, the metabolic network data can be supplied to the program through the
Metatool input format, as an SBML file or as stoichiometric matrix directly.
CellNetAnalyzer (von KAMP et al., 2017) is a MATLAB package with tools for the structural
and functional analysis of different types of biochemical networks. For all computations, only
the network topology is needed. CellNetAnalyzer allows the construction, input, and output
of network projects via the Network Composer, text files, or SBML. Furthermore, it is possible
to visualize network maps, either through import from KEGG or TRANSPATH or with external
drawing tools. The functional network analysis covers the characterization of functional states
of a network, the detection of functional dependencies, or qualitative predictions on effects of
perturbations. For mass flow networks, there are two kinds of methods - namely constraint-
based approaches and graph-theoretical analysis. Features are topological properties of the
network such as dead-end metabolites, blocked or parallel reactions, and enzyme subsets.
Metabolic flux analysis is also covered with the computation of steady-state flux distributions,
feasibility check of flux scenarios, or optimal flux distributions for arbitrary linear objective
functions. The computation of elementary modes for the metabolic path analysis is also
possible. Minimal cut set analysis can help to detect strategies for the repression of certain
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network functionality. From the graph-theoretical side, network properties such as shortest
path lengths, connectivity of the network, or network diameter can be computed.
The Genome-linked Application for Metabolic Maps (GLAMM) (BATES et al., 2011) is a web
interface unifying different tools for the reconstruction of metabolic networks from annotated
genome data, visualization of metabolic networks together with experimental data, and
investigation of the construction of novel transgenic pathways. GLAMM supports biological
retrosynthesis and integration with tools of MicrobesOnline.
The genome analysis and discovery system ERGO developed by Integrated Genomics is a
systems biology informatics toolkit for comparative genomics. With ERGO, one can capture,
query, and visualize sequenced genomes and assign functions to genes, integrate genes
into pathways, and identify unknown genes, gene products, and pathways. Its genomic
database integrates with a collection of microbial metabolic and nonmetabolic pathways
and proprietary algorithms. ERGO allows automated or manual annotation of genomes and
genes, pathway analysis, multiple genome comparison, functional analysis of microarray
data, data mining for the discovery of target genes, and in silico metabolic engineering and
strain improvement.
2.3 Network Reconstruction
A metabolic network reconstruction is a structured database combining the available ge-
netic, genomic, and biochemical data of an organism (REED et al., 2006). In general, a
genome-scale metabolic network reconstruction consists of a list of reactions including their
stoichiometry, the specific genes whose gene products are associated with these reactions,
supporting annotation, and literature references. The fundamental goal of a network recon-
struction is the accurate definition of the chemical transformations that take place among the
chemical components of the network (REED et al., 2006). The construction and curation of a
computational network links the organism’s genome and expression to metabolic reaction
fluxes, biomass, and energy production and consumption and enables the mathematical
representation of the reactions and metabolic processes occurring in the organism. Metabolic
networks can thus be used for in silico experiments (ZOMORRODI et al., 2012).
The process of compiling a (genome-scale) metabolic network can be broken up into five
major stages (THIELE et al., 2010), as depicted in Figure 2.1. Briefly, in the first stage, a
draft reconstruction of the network is built, which is refined in the second step. Then the
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Figure 2.1: Workflow of an iterative network reconstruction process
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network is converted to a mathematical model. In the fourth step, the reconstructed network
is validated and can then be used for further experiments.
The first stage consists of creating a draft reconstruction of the network, at minimum contain-
ing a list of genes with their associated reactions and the corresponding EC numbers. The
draft is based on the genome annotation for the most recent version of the target organism’s
genome and data from biological databases (Tables 2.1 to 2.5) and results in a collection of
the genome-encoded functions of the metabolism. The important information for each gene
is its function, its position in the genome and coding region, the strand and locus names, and
the protein it codes for. For eukaryotes, information regarding alternative transcripts is also of
interest because they may have distinct functions or a different cellular localization (THIELE
et al., 2010). Candidate metabolic functions for the draft reconstructions can be retrieved by
using GO categories, EC numbers, and biochemical databases (THIELE et al., 2010) (Tables
2.1 to 2.5). In general, the creation of a network draft is carried out automatically with the
help of different software tools (Table 2.7). The automated genome annotation process with
ERGO provides a draft annotation that requires manual curation to add organism specific
information. The Basic Local Alignment Search Tool (BLAST) (ALTSCHUL et al., 1990) is used
to annotate gene function based on orthology with other annotated genomes provided in
online databases as well as phylogenetic approaches. Model SEED starts with an unannotated
genome sequence and builds a draft metabolic network with gap filling and verification
features (HAGGART et al., 2011). To refine this draft, a manual reconstruction refinement
step is necessary.
The manual refinement step starts with an initial evaluation of the completeness of the draft
reconstruction for identifying missing functions in the network. The draft can be reviewed
pathway by pathway, starting from canonical pathways. The reactions of the model are
evaluated in their metabolic context such that missing gene annotations and missing reactions
can be identified easier. The use of network maps that show the environment of reactions is
also convenient. Such maps can be found in databases such as KEGG or in organism-specific
literature (THIELE et al., 2010). Correct stoichiometry requires complete balancing of ele-
ments and charges. Some databases may lack information on protons and water, for example.
The incorporation of thermodynamic information is also of great value for the network model.
Reaction directions can be based on the reaction’s thermodynamic favorability, which can
be determined from Gibbs free-energy changes. This information can be obtained from
literature. However, the available data are rarely sufficient for genome-scale reconstructions,
but rather for smaller models. Software, such as the biochemical thermodynamics calculator
eQuilibrator (FLAMHOLZ et al., 2012), can be used to estimate thermodynamic parameters for
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biological reactions in networks and pathways (NOOR et al., 2014) using the group contribu-
tion method (NOOR et al., 2013). If no thermodynamic information is available, the reaction
should be left reversible. Organism-specific functions should also be taken into account,
such as the use of substrate and cofactors, which can differ between different organisms.
The review of primary literature dealing with the metabolism and function of the organism
is necessary to identify these organism-specific characteristics. For a growing number of
organisms, specific textbooks exist, which are a resource for additional information. When
organism-specific information is not available to the desired extent, data from phylogenetic
neighbors can be taken into account. Gene-protein reaction relationships, which connect the
genes with their associated enzymes via Boolean logic, allow the simulation of phenotypic
effects of gene knockouts. Also, the compartmentalization information for metabolite and
reaction localization as well as intracellular transport reactions have to be checked. If no
sufficient data are available, the respective proteins should be assumed to reside in the cytosol.
However, incorrect assignment can lead to additional network gaps (THIELE et al., 2010). For
cell-free systems, e.g. cell lysates, there exist no compartments. A network reconstruction for
such a system thus has no need for compartmentalization, intracellular transport reactions
and separated metabolite pools. They can be neglected in the reconstruction process.
Furthermore, biomass composition, maintenance parameters, and growth conditions of the
organism are to be determined by different experimental and computational methods. When
designing a biosynthetic synthesis pathway, the selection of substrates and cofactors has to
take into account toxicity for the host organism. For living organisms, non-toxic substrates
and cofactors should be preferred. This does not need to be incorporated into network
reconstructions for cell-free systems, where reactants can also be present in non-physiological
concentrations.
The conversion from the network reconstruction to a mathematical model for validation and
in silico applications consists of three steps, which can mostly be automated with suitable tools.
The first step is the mathematical representation of the network as a stoichiometric matrix.
In the second step, the boundaries of the system are defined. For each metabolite that can be
consumed or secreted, an exchange reaction is added to allow the definition of environmental
conditions for in silico simulations. This is only needed for network reconstructions of living
organisms and is omitted in network reconstructions of cell-free systems. For network
reconstructions of living organisms, constraints are added to the model to turn it into a
condition-specific model. Thermodynamic data for enzyme capacities or regulation help to
determine a set of feasible steady-state flux solutions.
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The evaluation stage includes network verification, evaluation, and validation steps to help
detect gaps in the network. To find candidates for filling gaps, an intensive literature search
is needed that helps to identify the environment of the dead-end metabolites. Databases
such as ATLAS of Biochemistry (HADADI et al., 2016) and other cheminformatic tools (e.g.
the rePrime procedure (KUMAR et al., 2018)) can also help to close network gaps with de
novo reactions. Methods like BridgIT (HADADI et al., 2019) can be used to identify genes
and proteins for orphan reactions that are not associated with enzymes.
For network reconstructions of living organisms one must also take care of stoichiometrically
balanced cycles formed by internal network reactions that can carry fluxes despite closed
exchange reactions (THIELE et al., 2010). The model must be tested for its ability to syn-
thesize all biomass precursors, such as amino acids, nucleotide triphosphates, or lipids with
different medium compositions. This can be done by growing the organism on specific carbon
sources (HAGGART et al., 2011). It should be checked if the model could reproduce known
incapabilities of the organism. It is also advised to compare the predicted physiological
properties with known properties such as carbon splits in the central metabolic pathways of
the organism. For cell-free network reconstructions, these steps can be omitted.
Network reconstructions can be used for several major applications that address different
aims of these models (OBERHARDT et al., 2009), such as using metabolic network reconstruc-
tions for putting high-throughput experimental data into context. They can also be used for
discovery of network properties, hypothesis-driven discovery, and exploration of multispecies
relationships. Network reconstructions also have applications in metabolic engineering,
where they can be used for constraint-based modeling and the in silico prediction of possible
cellular phenotypes without the need for kinetic data. The main concept behind network
metabolic modeling is the identification and mathematical definition of constraints for the
separation of feasible and infeasible metabolic behavior. These constraints are usually much
easier to identify than kinetic parameters. There are three types of constraints: Physicochem-
ical constraints deal with mass and energy conservation, the dependency of reaction rates on
metabolite concentrations, and the negative free-energy change for spontaneous reactions.
Environmental constraints are imposed as a result of specific conditions such as nutrients,
whereas regulatory constraints express the effects of gene expression and enzyme activity
regulation properties.
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2.4 Network Representation
Metabolic network models can formally be described as graphs G(V, E), where V is the set
of vertices and E is the set of edges connecting node pairs. In a directed graph, the edges
are ordered, whereas in an undirected graph an edge is represented by an unordered node















Figure 2.2: Graph representations. Rounded squares: metabolites; circles: reactions.
graph (Figure 2.2(a)), the nodes represent the chemical compounds. An (un)directed edge
connects two compounds if they are substrate and product of the same reaction. The dual
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form of the compound graph is the reaction graph (Figure 2.2(b)), where the nodes represent
reactions. Edges in this graph connect two reactions if one reaction has products that are
substrates of the other reaction. Both types of representation have similar limitations, as
they are both ambiguous and do not represent all information of the network. Another type
of graph representation is the bipartite graph (Figure 2.2(c)), in which there are two classes
of nodes representing compounds and reactions in the graph. Directed or undirected edges
in a bipartite graph are only possible between two nodes of different classes. A substrate is
defined by a directed edge from a compound to a reaction node, a product by an edge from
a reaction to a compound node. An equivalent representation of a bipartite graph and also
the generalization of a compound graph is a hypergraph (Figure 2.2(d)) with directed or
undirected edges. In such a graph, a hyperedge relates a set of substrates to a set of products.
This graph type allows an unambiguous representation of reactions and compounds, but it
has limited coverage because reaction control factors cannot be represented. Diverse graph
types and data models for biochemical pathways are reviewed in more detail in (DEVILLE
et al., 2003).
A biological pathway can be defined in several different ways, depending on the underlying
biological network representation or the context in which the pathway is considered. When
metabolism is defined as a network of chemical reactions catalyzed by enzymes and connected
by substrates and products, then the most basic definition of a metabolic pathway is a
coordinated series of reactions (DEVILLE et al., 2003). Given a compound graph, a pathway
can be a sequence of metabolites that are linked by reactions or substrate-product pairs.
In the simplest case, the sequence is a linear path from a start metabolite A to a target
metabolite B (Figure 2.3(a)). In most cases, this definition is too basic. Especially in the
context of biological synthesis, this kind of pathway does not cover all information needed.
It is much more meaningful to look at branched pathways. A branched pathway to a given
target metabolite does not have a single start metabolite, but it rather can have multiple start
metabolites by taking into account every substrate of each reaction involved in the pathway
to produce the target metabolite B (Figure 2.3(b)).
A basic mathematical representation of metabolic networks is the stoichiometric matrix. It
represents its charge and elementary balanced metabolic reactions and thus quantifies the
stoichiometric relationship between the metabolites in a reaction. The rows and columns of
the matrix correspond to the metabolites and reactions of the network. Its nonzero elements
are the stoichiometric coefficients, which are positive for products and negative for substrates.
For genome-scale metabolic networks, the stoichiometric matrix is sparse because relatively
few metabolites participate in a given reaction.
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(b) Branched pathway to a target metabolite B.
Figure 2.3: Pathway definitions. Rounded squares: metabolites; circles: reactions.
Another quite simple representation method for metabolic networks is compiling all informa-
tion in spreadsheets. The spreadsheet should contain all gene names and their abbreviations.
For each reaction, the reactant, substrate, product symbols, balanced stoichiometry, re-
versibility, compartment, associated protein, and its EC number should be included. Also of
importance are literature references and a confidence rating for each annotation entry as
well as comments.
SBML is a machine-readable format for representing biological models. Its basic idea is
to cast a network reconstruction into a formal, computable form, thus allowing network
analysis using simulations and other mathematical methods.
The SBGN (LE NOVERE et al., 2009) is a project that aims to standardize the graphical
notation used in maps of biological processes. Currently, there are three different languages
for different types of network maps. The Process Description (PD) language (ROUGNY et al.,
2019) can be used to depict temporal courses of biochemical interactions of a network.
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Relationships between entities of a network can be modeled with the Entity Relationship
(ER) language (SOROKIN et al., 2015). The Activity Flow (AF) language (MI et al., 2015)
visualizes the information flow between biochemical entities in the network, such as for
representation of the effects of perturbations on the network.
BioPax (DEMIR et al., 2010) is an open standard language for the integration, exchange and
visualization of biological pathways.
2.5 Metabolic Network Design and Manipulation
The planning of a biochemical synthesis in permeabilized cells involves primarily finding
a synthesis route starting from available, inexpensive, and stable substrates. The overall
goal is to obtain high product concentration with high yield and selectivity in the shortest
possible time. High yield and selectivity can only be obtained if undesired side reactions do
not take place. The products of undesired side reactions will also complicate downstream
processing. Side reactions do not occur if one of the substrates required is missing. The
substrate composition is a design variable when using permeabilized cells as biocatalysts.
Side reactions can be eliminated by the deletion of the corresponding gene or by the addition
of a selective inhibitor. A major engineering task of biosynthesis in permeabilized cells is the
regeneration of cofactors, such as NAD(P)H (LEE et al., 2013) or ATP (HORINOUCHI et al.,
2006; HORINOUCHI et al., 2012).
Metabolic engineering is the manipulation of enzymatic, transport, and regulatory functions
of a cell through recombinant DNA technologies. One of its important objectives is the
improvement of the cellular phenotype or the yield of a desired product. Traditionally, this is
done by rationally selected gene deletions or overexpression of native and heterologous genes
in an organism. To remove undesirable metabolic pathways in an organism, site-directed
mutagenesis or homologous recombination can be used. To increase biochemical yields
and add new functions, heterologous genes or even complete pathways can be introduced
into the organism. In silico metabolic models allow rational predictions of the phenotypical
response of changes in culture media, gene knockouts, and the incorporation of heterologous
enzymes and pathways into an organism (BLAZECK et al., 2010).
Flux balance analysis is a widely used constraint-based method in metabolic engineering
for studying biochemical networks. It allows for the in silico prediction of flux profiles that
optimize a cellular objective, depending on the problem. Often, the biomass production or the
production rate of a certain metabolite of interest is used as an objective. The fundamental
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assumption for flux balance analysis is that the metabolism in the cell is at steady state as
well as all reaction fluxes and metabolite concentrations (HAGGART et al., 2011). The input
for flux balance analysis is the mathematical representation of the metabolic network as
a stoichiometric matrix. The stoichiometric coefficients in the matrix constrain the flow
of metabolites through the network. These steady-state mass balance equations for each
metabolite and the environmental and growth conditions can be described mathematically
in the form of constraints for an optimization problem. The metabolite balance equation is a
homogeneous system of linear equations S · v(t) = 0, where S is the stoichiometric matrix
and v(t) is the vector of reaction rates. It requires that each metabolite is consumed at the
same rate as it is produced (TERZER et al., 2009). For the quantitative determination of the
metabolic fluxes, linear programming can be used to solve the stoichiometric matrix for a
given objective function under various constraints (T. Y. KIM et al., 2012). A linear program
is a mathematical optimization model which requires maximizing or minimizing a given
objective under a finite set of given constraints. The constraints describe the space of all
eligible possibilities from which an optimal solution can be selected. They are generally
given in the form of equalities and/or inequalities. In its canonical form, a linear program it
can be formulated as
maximize cTx
subject to Ax≤ b
and x≥ 0
where x is the vector of variables; c and b are vectors of known coefficients; and A is a
known matrix of coefficients. (·)T is the matrix transpose. A feasible solution of the linear
program is any assignment of x satisfying all constraints (CORMEN et al., 2009). For an integer
linear program all variables are required to be integers, while in a MILP also non-integer
variables are allowed. Finding a feasible solution for a linear problem can be generally
done in polyomial time, for example with the simplex algorithm (CORMEN et al., 2009).
However, finding a feasible solution of a integer linear problem is NP-hard, so there are no
polynomial-time algorithms known. Nevertheless, commercially available tools such as the
IBM CPLEX Optimizer as well as non-commercial solvers allow for the fast computation of a
feasible solution. Note that in the worst case the running time is not polynomial.
Constraint-based methods focus only on reaction fluxes, neglecting enzyme kinetics and
regulations that can influence the actual fluxes. Therefore, they have some limitations in
their predictive capabilities (DUROT et al., 2009). However, they can be computed very
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efficiently, even for large networks. Elementary mode analysis is an important method for
metabolic network studies (von KAMP et al., 2006), allowing the enumeration of all indepen-
dent minimal pathways in the network that are stoichiometrically and thermodynamically
feasible. Elementary flux modes are independent flux distributions of a metabolic network at
steady state. The inputs for elementary mode analysis are the reaction stoichiometries and
reversibilities. All metabolites in the network are classified as either internal or external. The
internal metabolites are balanced and the external metabolites are assumed to be buffered.
The computation of elementary modes in large networks is difficult due to its combinatorial
complexity (KLAMT et al., 2007). Once elementary modes are computed, the deletions
necessary for the elimination of undesired side product formation can be directly identified.
It requires that each metabolite is consumed at the same rate as it is produced (REED et al.,
2006). For the quantitative determination of the metabolic fluxes linear programming can
be used to solve the stoichiometric matrix for a given objective function under various con-
straints (ZOMORRODI et al., 2012). The constraints of the problem describe the space of all
eligible possibilities from which an optimal solution can be selected. It has been shown that
it is even possible to directly identify successful targets for the overexpression of enzymes
just based on the known stoichiometry of a network (BOGMAN et al., 2003; HAGGART et al.,
2011; NEUNER et al., 2011; RYAN et al., 1991).
However, these methods are not directly applicable for permeabilized cells because they as-
sume a steady-state in the network. This will be discussed in detail in Section 4.1 Background
where a different approach tailored for cell-free systems is presented.
CHAPTER 3
Aims and Scope
This thesis has two main aims. The first aim is to design a comprehensive method for
finding and analyzing pathway candidates for synthesis in genome-scale metabolic network
reconstructions of cell-free systems. The second aim of this thesis is to develop a method for
creating and characterizing such network reconstructions from KEGG data for the planning
of biosynthetic production pathways using cell-free systems.
In Part II Path-Finding and Network Analysis for Multi-Enzyme Biocatalysis, a newly developed
method for finding pathways in a genome-scale metabolic network reconstruction is discussed.
The method is based on a MILP and combines both topology of the graph based on the network
and the stoichiometry of the reactions in the network model. The algorithm only requires
the specification of the target product of interest to find pathways starting from arbitrary
substrates and a set of ubiquitous cofactors (e.g. nucleoside triphosphates such as ATP;
or NAD(P)H) and inorganic metabolites such as water or CO2. A set of different ranking
criteria to help finding well-designed and meaningful synthesis pathway candidates is also
developed. These criteria include pathway length, reaction thermodynamics, the number
of heterologous enzymes for a given host organism or cofactor requirement of the pathway,
amongst others. The features of the method are presented using geranyl pyrophosphate
(GPP), amygdalin, pyrrolysine and (S)-2-phenyloxirane as examples for target metabolites.
In Part III Network Reconstructions for Cell-Free Systems a method for the reconstruction of
genome-scale metabolic network models based on KEGG data is presented and discussed.
Not suitable data, e.g. generic metabolites, general reactions and reactions with invalid
stoichiometry are removed with a filtering scheme. The network models also comprise
stoichiometric and thermodynamic data that allow the definition of constraints to identify
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potential pathways. A pan-organism network reconstruction containing all suitable reac-
tions in KEGG is assembled. Furthermore, single organism network reconstructions from
several organisms important in biotechnological production and scientific research, such as
Escherichia coli and Corynebacterium glutamicum, amongst others, are established. These
network models are analyzed with the help of graph theoretical methods to identify a set of
metabolites that are potentially reachable from a defined set of starting metabolites. It is
discussed how they can be used for the planning of biosynthetic production pathways. The
usage of the path-finding tool is presented using the example of UDP-glucose as a target.
The workflow for network reconstruction and analyzing together with the path-finding
method describes a powerful and highly customizable toolbox usable for the design of multi-
enzyme biosynthetic production pathways. The data resulting from the studies presented
in this work can be directly applied to the planning of biosynthetic production pathways
and can also help setting up custom network reconstructions or improving existing network
models.





Network Design and Analysis for Multi-Enzyme Biocatalysis
The following chapter is based on the published research article
BLASS, L. K., WEYLER, C., & HEINZLE, E. (2017): Network design and
analysis for multi-enzyme biocatalysis. BMC Bioinformatics (Aug. 2017),
vol. 18([1]): 366. https://doi.org/10.1186/s12859-017-1773-y
that I co-authored.
Appendix A is based on the the supplementary material of this research article.
Abstract
As more and more biological reaction data becomes available, the full exploration of the en-
zymatic potential for the synthesis of valuable products opens up exciting new opportunities
but is becoming increasingly complex. The manual design of multi-step biosynthesis routes
involving enzymes from different organisms is very challenging. To harness the full enzy-
matic potential, we developed a computational tool for the directed design of biosynthetic
production pathways for multi-step catalysis with in vitro enzyme cascades, cell hydrolysates
and permeabilized cells.
We present a method which encompasses the reconstruction of a genome-scale pan-organism
metabolic network, path-finding and the ranking of the resulting pathway candidates for
proposing suitable synthesis pathways. The network is based on reaction and reaction pair
data from the KEGG and the thermodynamics calculator eQuilibrator. The pan-organism
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network is especially useful for finding the most suitable pathway to a target metabolite
from a thermodynamic or economic standpoint. However, our method can be used with
any network reconstruction, e.g. for a specific organism. We implemented a path-finding
algorithm based on a MILP which takes into account both topology and stoichiometry of
the underlying network. Unlike other methods we do not specify a single starting metabo-
lite, but our algorithm searches for pathways starting from arbitrary start metabolites to a
target product of interest. Using a set of biochemical ranking criteria including pathway
length, thermodynamics and other biological characteristics such as number of heterologous
enzymes or cofactor requirement, it is possible to obtain well-designed meaningful pathway
alternatives. In addition, a thermodynamic profile, the overall reactant balance and potential
side reactions as well as an SBML file for visualization are generated for each pathway
alternative.
We present an in silico tool for the design of multi-enzyme biosynthetic production pathways
starting from a pan-organism network. The method is highly customizable and each module
can be adapted to the focus of the project at hand. This method is directly applicable for (i)
in vitro enzyme cascades, (ii) cell hydrolysates and (iii) permeabilized cells.
4.1 Background
While thousands of enzymes are already known, numerous new enzymes or new enzymatic
activities are still discovered every year. Many of these biocatalysts accept multiple substrates
and even catalyze different reactions. From a biotechnological point of view, the enzymatic
potential of nature can be considered an extremely versatile tool potentially giving access to
countless valuable products ranging from bulk chemicals to most complex drug compounds.
The methods for such syntheses can range from using single isolated enzymes over multi-
enzyme systems or enzyme cascades up to syntheses with cell lysates or permeabilized cells
(HEINZLE et al., 2013).
However, the full exploration of the enzymatic potential is often hampered by the sheer
amount and complexity of available reaction data. When manually designing a multi-step
synthesis route to a certain metabolic intermediate, the network of alternative synthesis
pathways quickly grows highly complex as more reaction steps are introduced. Additionally,
assembling all reactions that lead to each reactant is extremely time consuming. The manual
determination of the most suitable pathway candidate is challenging as multiple aspects such
as thermodynamics, cofactor use, etc. need to be considered. To more easily harness the
full potential of the enzymatic toolbox we developed a computational tool for the directed
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design of biosynthetic production pathways for interesting products in cell extracts and
permeabilized cells.
The search for pathways in genome-scale metabolic networks is a common task of wide
interest and there is a large variety of path-finding and pathway design methods. Most of
those methods can be categorized into one of two types, namely stoichiometric methods and
graph-based methods. Stoichiometric methods make use of the stoichiometry of a network
to analyze the metabolism under the assumption of a steady-state condition. Popular and
mathematically well understood methods are for example elementary flux modes (SCHUSTER
et al., 1999) or flux balance analysis (PHARKYA et al., 2004; TERVO et al., 2016). Graph-
based methods in general neglect stoichiometry and treat the networks as graphs in a
mathematical sense and search for pathways based on connectivity (FAUST et al., 2009),
with the use of atom or atom group tracking (BLUM et al., 2008a, 2008b; HUANG et al.,
2017), retrosynthesis (CARBONELL et al., 2011; HATZIMANIKATIS et al., 2005), heuristic
search algorithms (MCCLYMONT et al., 2013) or evolutionary algorithms (GERARD et al.,
2015). In the last years, methods combining stoichiometry and structural properties of
networks emerged, e.g. the so called carbon flux paths proposed by Pey et al. (PEY et al.,
2014; PEY et al., 2011). However, the majority of these methods tackles the problem of
finding pathways between two given metabolites and does not take into account a search
starting with an arbitrary metabolite in the network. Another drawback of these methods for
our focus of application is that most of them assume a steady-state condition for the major
part of the network. This is valid for living cells or cells with intact membranes. In these
cases the actual reactions are running in a cellular compartment that keeps all intermediates
separated from the bioreactor, whereas in the case of enzyme cocktails and permeabilized
cells the reaction compartment is identical to the bioreactor used. Examples of the latter
type of reaction systems are becoming increasingly popular (CARSTEN et al., 2015; DUDLEY
et al., 2016; KARIM et al., 2016; KOIZUMI, 2003; KOIZUMI et al., 2000; KOIZUMI et al., 1998;
KRAUSER et al., 2015; WEYLER et al., 2015).
We thus propose a tool which encompasses the reconstruction of a genome-scale pan-organism
metabolic network, the implementation of a path-finding algorithm and the ranking of path-
way candidates for proposing suitable synthesis pathways starting from arbitrary substrates.
4.2 Methods
In the following we will present the individual parts of our method. Figure 4.1 shows the
workflow through its different components.
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Figure 4.1: Workflow through the components of our tool. We start with a network reconstruction
which is then used for path-finding with the presented MILP. The resulting pathway candidates
are ranked according to the different ranking criteria.
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The first step is the network reconstruction where the network is built with data from KEGG
(KANEHISA et al., 2000; KANEHISA, SATO, KAWASHIMA, et al., 2016) and the biochemical
thermodynamics calculator eQuilibrator 2.0 (FLAMHOLZ et al., 2012; NOOR et al., 2013).
Details on how the network is compiled are given in Section 4.2 Network Reconstruction.
The path-finding in the network is based on an optimization algorithm developed by Pey et
al. (PEY et al., 2011). It combines graph-based path-finding and reaction stoichiometry in a
MILP. The algorithm with our extensions is presented in detail in Section 4.2 Mathematical
Model. In a further stage the resulting pathway candidates are ranked using different criteria.
We will give details on the ranking in Section 4.2 Filtering and Ranking. The output is a
list of ranked pathway candidates which can be assessed with expert knowledge to help
determining the most suitable synthesis pathway for a desired product.
Network Reconstruction
We combine data from different KEGG databases and eQuilibrator 2.0 for the reconstruction
of a pan-organism network with data from all organisms contained in KEGG release 78.1
from May 1, 2016.
Reaction and Reaction Pair Data
The reaction network was reconstructed with COnstraint-Based Reconstruction and Analysis
(COBRA) Toolbox (SCHELLENBERGER et al., 2011) using reactions from KEGG REACTION.
We excluded reactions with the comments ‘generic’and ‘incomplete’in their data entries;
reactions with ambiguous stoichiometry with stoichiometric coefficient n in the reaction
equation; as well as reactions involving glycans with G numbers in KEGG.
From all remaining reactions in the model we built a network of reaction pairs, the so called
arcs. A reaction pair is a biologically meaningful substrate-product pair in a reaction. We
derived the arcs from the KEGG RPAIR database 1 containing reaction pairs for each reaction.
The reaction pairs in KEGG are classified into five categories (KOTERA, HATTORI, et al.,
2004) from which we used the main-pairs, describing the main changes on the substrates
in a reaction and the trans-pairs which describe transferase reactions. We did not use the
remaining three types cofac-pairs, ligase-pairs and leave-pairs. However, they can be included
at user’s discretion.
1 discontinued since KEGG release 80.0, October 1, 2016
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Our network reconstruction comprises a total of 9038 reactions (10160 including reversible
reactions), 7405 metabolites and 14803 arcs.
Thermodynamic Data
The KEGG REACTION database does not contain any detailed information about reaction
directions, so we incorporated thermodynamic data from the biochemical thermodynamics
calculator eQuilibrator 2.0. The component contribution method used (NOOR et al., 2013)
provides different types of the reaction Gibbs energy. ∆r G
′
° expresses the change of the
Gibbs free energy of a reaction at a given pH and ionic strength I in 1 M concentration of the
reactants. However, for metabolic reactions in cells it makes more sense to use physiologically
meaningful concentrations. For ∆r G
′m the concentration of the reactants is thus set to 1 mM.
For all calculations standard parameters are used which are a temperature of 25 °C (298.15
Kelvin), a pH of 7 and a pressure of 1 bar. We set the threshold for the discrimination of
reversible and irreversible to ∆r G = 15 kJ/mol. Reactions without available thermodynamic
data are considered irreversible in the direction given in the reaction equation from KEGG.
Network Details
We categorize the metabolites in the model into different sets which we treat differently in
our path-finding method. All sets are given in Additional file 1 of (BLASS et al., 2017). A
Venn diagram of these sets is depicted in Figure 4.2.
As start metabolites S we denote all metabolites that can be potential start points of a
metabolite path. A metabolite path is a sequence of metabolites through the network
connected by arcs. We compiled the list of possible start metabolites with all metabolites
in the model contained in arcs with a molecular mass between 0 and 300. A subset of
the start metabolites are the so called basis metabolites B. They are an expert-curated set
of metabolites that are hubs of the arc network, easily available and inexpensive, such as
D-glucose (C000311) or pyruvate (C00022).
As cofactors we denote metabolites that are required for the activity of the enzymes catalyzing
the reactions in the network but are not directly part of the reaction chain. We exclude
arcs containing cofactors from the set of arcs to prevent biologically meaningless shortcuts
in the network. The list is expert-curated and contains mono-, di- and triphosphates (e.g.


















Figure 4.2: Venn diagram with the different metabolite categories in the network reconstruction.
Metabolites M: all metabolites in the network; metabolite pool Em: metabolites considered
available from start; start metabolites: all metabolites in the model contained in arcs with a
molecular mass between 0 and 300; basis metabolites: expert-curated subset of start metabolites;
cofactors: cofactors for enzymes; excluded metabolites: treated as cofactors; external metabolites:
not contained in the metabolite pool, cannot be externally supplied; generic metabolites: marked
as ‘generic’ in their KEGG entry; the grey background indicates the set that can contain the
product P.
adenosine 5’-monophosphate (AMP) (C00020), adenosine 5’-diphosphate (ADP) (C00008)
and ATP (C00002)), electron carriers such as nicotinamide adenine dinucleotide (NAD+)
(C00003) and others. The mono- and diphosphates are usually not considered cofactors, but
we chose to incorporate them into the list to avoid unnecessary interconversions between
them on the pathway candidates. The set of excluded metabolites is treated in the same
way as the cofactors. It contains metabolites that are considered as freely available, such as
water, oxygen or CO2. As the metabolite pool Em we denote the superset of metabolites we
consider as freely available. This set consists of start metabolites, basis metabolites, cofactors
and excluded metabolites. As external metabolites we denote all metabolites that are not
contained in the metabolite pool. They have to be produced in a production pathway and
cannot be externally supplied. Generic metabolites are metabolites that are marked as ’generic’
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in their KEGG entry, such as peptide (C00012) or protein (C00017). In our network we treat
them as external metabolites and exclude arcs containing those metabolites from the arc
network. The pool of external metabolites also contains metabolites with arcs that are not
start metabolites as well as all other metabolites that are not part of any other set.
Path-Finding
In the following we introduce our method for finding pathway candidates in the network by
means of a MILP.
Mathematical Model
Given a metabolic model with the set of reactions R and the set of metabolites M we build the
network of arcs. We also use the |M|-by-|R| stoichiometric matrix of the network, where
each row corresponds to a metabolite and each column corresponds to a reaction. An entry
in the matrix represents the stoichiometric value of a metabolite in the respective reaction,
where negative values indicate a reactant and positive values indicate a product. Reversible
reactions appear in the model as two different reactions with opposite directions.
MILP
The algorithm presented is based on an algorithm proposed by Pey et al. (PEY et al., 2011).
However, in comparison to the original algorithm we changed the problem statement. Pey et
al. dealt with the question of finding the K-shortest flux paths between a given source and
a target metabolite. Different from this problem statement we do not specify any specific
starting metabolite, but our algorithm identifies suitable starting metabolites for finding a
pathway to a target metabolite P. In our definition, a pathway consists of two parts. The first
part is a sequence of metabolites connected by reactions. It starts with a reaction that has one
of the possible start metabolites as substrate and ends with a reaction with the desired target
metabolite as a product. This part is called the linear path. The second part is a minimal set
of reactions supplying substrates that are needed by the reactions on the path which are not
contained in the metabolite pool. These are called supplying reactions.
We introduce the set of binary variables ui j which are 1, if an arc from i to j is part of the
linear path, and 0 otherwise (for i, j = 1, . . . , |M |). The first constraint given by equation (4.1)
establishes that there is exactly one arc on the linear path ending in the target metabolite P,
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uiP = 1 (4.1)
|M |∑
j=1
uP j = 0 (4.2)
The two constraints ensure that the target P is always the last node on each identified path
and thus the path actually ends with the desired product. Both constraints have been adopted
from (PEY et al., 2011). Inequality (4.3) states that the number of arcs entering a node l







ul j l ∈ S; l 6= P (4.3)
This means that a metabolite l is either the starting metabolite of a path (
∑
uil = 0 and∑




ul j). In the trivial case where l is
not on the path, both sums are zero. The idea of the constraint has been adopted from (PEY
et al., 2011). However, we changed it to incorporate the set of starting metabolites, which
has not been introduced in the original MILP. For the set of basis metabolites B we introduce
a constraint formulated in equation (4.4) stating that the number of arcs entering a node l
from the set of basis metabolites B should be zero. This means that a basis metabolite can
only appear as the first metabolite in a metabolite path and not as an intermediate.
|M |∑
i=1
uil = 0 l ∈ B; l 6= P (4.4)
For all other nodes k in the network except the target node P the number of in-going arcs






uk j k ∈ M \ S; k 6= P (4.5)
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This means that if an arc is entering an intermediate node k, then there must also be an arc
leaving this node. Constraints (4.3) to (4.5) ensure that a path can only start with a start
metabolite contained in the set of possible start nodes S. This constraint was taken from
(PEY et al., 2011), but has been adapted for start metabolites. Constraint (4.6), which was
adopted from (PEY et al., 2011), forces nodes on a path to be unique, i.e. at most one arc
can enter any given node.
|M |∑
i=1
uik ≤ 1, k = 1, . . . , |M | (4.6)
Constraints (4.1) to (4.6) ensure that a solution contains a connected simple path from a
start node of the set of start nodes S to a given end node P.
The next set of constraints deals with the feasibility of the linear path in the given network.
Given are the stoichiometric coefficients Smr for a metabolite m in reaction r (for m =
1, . . . , |M |, r = 1, . . . , |R|). The variables vr assign each reaction r a non-negative flux.
Constraint (4.7) expresses that the external metabolites are not necessarily balanced and
can only be produced, but not be taken up. Only metabolites from the metabolite pool Em
containing the set of start metabolites, basis metabolites, cofactors and excluded metabolites
can be taken up. This means that all substrates on the pathway must be producible with




Smr vr ≥ 0, ∀m ∈ E, m /∈ Em (4.7)
We added constraint (4.8) to make sure the target metabolite P can only be produced.
|R|∑
r=1
SPr vr ≥ 1, (4.8)
With constraints (4.9) and (4.10), (adopted from (PEY et al., 2011)), we introduce the binary
variable zr which is 1, when reaction r has a flux and 0 otherwise. All fluxes are scaled
between 1 and a chosen positive value Max with Max ≥ 1. This constraint relates fluxes in
the flux distribution defined by vr to reactions.
zr ≤ vr , r = 1, . . . , R (4.9)
and vr ≤ Max · zr , r = 1, . . . ,R (4.10)
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Constraint (4.11) states that a reaction and its reverse cannot appear together in a valid flux
distribution to exclude trivial cycles. This constraint was adopted from (PEY et al., 2011)).
zλ + zµ ≤ 1 (4.11)
∀(λ,µ) ∈ B = {(λ,µ)|λ and µ are reverse}




di jr · zr ≥ ui j i = 1, . . . ,|M |; j = 1, . . . ,|M |; i 6= j (4.12)
The binary coefficients di jr are 1, if there exists an arc between the metabolites i and j in
reaction r and 0 otherwise. If an arc from i to j is used in the path (ui j = 1) then at least
one reaction r containing this arc (di jr = 1) has to be active. This constraint was adopted
from (PEY et al., 2011)).
Constraints (4.7) to (4.12) define a valid flux distribution for the pathway ensuring that the
found path is feasible.












As proposed by (PEY et al., 2011) we minimize the number of arcs ui j used but additionally
we also minimize the number of active reactions on the whole pathway candidate.
A solution to the MILP described by equations (4.1) to (4.13) is a sequence of arcs given by
the values of ui j and the set of active reactions given by the values of zr . By minimizing the
objective function we ensure that the linear path is connected and cycle-free and the number
of active reactions and thus of supplying reactions is minimal. From the active reactions we
determine those corresponding to the active arcs, denoted as Z ′. One solution represents
one pathway candidate.
To find further solutions we have to exclude solutions with the same active arcs and the same
reactions Z ′. Note that a valid new solution can have exactly the same set of active arcs as a
previous solution if Z ′ is different, since an arc can be derived from more than one reaction.
Let Uki j be the value of ui j for the k-th unique solution with respect to the metabolite path.
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To indicate that a solution is exactly the same as solution k regarding the metabolite path,
we introduce a binary variable sk. When a solution is different from solution k regarding the
metabolite path, sk has to be 0 and 1 otherwise. Whenever we find a metabolite path U
k′ we






















i j )ui j + sk′ |M |
2 ≤ |M |2 (4.15)
Constraints (4.14) and (4.15) establish that, whenever we find a new solution U and sk′ is
set to 1, we know that U = Uk
′
. In more detail, constraint (4.14) ensures that if sk′ is 1 all
arcs of solution k′ are also active. Additionally, constraint (4.15) forbids U to contain any arc
that was not present in Uk
′
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i j − 1 (4.16)
Constraint (4.16) ensures that a valid new solution has to fulfill one of the following three
properties. It has either exactly the same metabolite path Uk
′
; or at least one of the arcs
from the previous metabolite path Uk
′
is not active; or all arcs from Uk
′
are active and one
arc entering the first metabolite αk
′
is active extending a previously found metabolite path.
This constraint also ensures that sk′ is set to 1 if U = Uk
′
. Constraint (4.17) is always added
for each new solution. Assume the found metabolite path is the same from solution k (Uk).
Let Z ′li indicate whether reaction i is active in solution l and corresponds to an active arc in
Uk. The number of ones in Z ′l is denoted by ml . This constraint prevents to find a second




Z ′li zi + sk|R| ≤ ml − 1+ |R| (4.17)
Figure 4.3 depicts an exemplary pathway to the target metabolite P illustrating a possible
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Figure 4.3: Exemplary pathway illustrating a possible solution. The squares depict metabolites,
the circles represent reactions. The pathway is a feasible synthesis pathway from M1 to the
product P.
linear path, whereas the dark orange square P is the target metabolite. The light blue squares
are metabolites from the metabolite pool. The linear path highlighted in yellow is defined
through constraints (4.1) to (4.6). One of the substrates for reaction R3, metabolite M4, is
not available in the metabolite pool and thus must be supplied by other reactions. These
supplying reactions are defined by constraints (4.7) to (4.12). In this example, reaction R4
depicted by the white circle is added to the resulting path. The overall pathway is a synthesis
pathway from M1 to the desired product P that is feasible within the given network.
Filtering and Ranking
We rank the pathway candidates generated by the MILP by different criteria in order to
highlight the most meaningful candidates for the synthesis of the desired product. As a global
optimization method, the MILP cannot take into account if the first reaction of a pathway
candidate is feasible only with metabolites in the metabolite pool. We thus have to perform
a filtering step before the ranking to eliminate those pathway candidates that do not comply
with this requirement. The ranking criteria are listed in Table 4.1.
The first criterion is the number of active reactions in the pathway candidate. Shorter
pathways favor a fast product formation, a reduced substrate demand and are generally
48 Chapter 4 Network Design and Analysis for Multi-Enzyme Biocatalysis
Table 4.1: Ranking criteria in the order they are applied to the pathway candidates.
position criterion comment
1 number of active reactions shorter pathways are favorable
2 candidate starts with basic metabolites only ‘yes’ is preferred
3 number of reactions without ∆r G as few as possible
4
∑
(∆r G + |∆r G|) preferably all ∆r G are negative
5
∑
∆r G negative is preferred
6 number of heterologous enzymes as few as possible
7 number of cofactors as few as possible
easier to realize than a pathway with more reactions. The second ranking criterion prefers
pathway candidates starting with basic metabolites only. A further ranking criterion favors
pathways for which there is thermodynamic information available. This is based on the notion
that reactions without known or assessable ∆r G are often poorly described. Another ranking
criterion is the sum of the ∆r G’s and the absolute value of those ∆r G’s
∑
r(∆r G + |∆r G|)
for all reactions r in the linear path of the pathway candidate. Ideally this sum is 0, since
then each reaction has a negative ∆r G. Therefore, pathway candidates with positive ∆r G of
intermediate reactions are ranked down, as they would lead to kinetic traps. Furthermore,
the pathway candidates are ranked by the overall thermodynamics of the linear path of the
pathway candidate. Pathways with a negative overall ∆r G are preferred over those with a
positive overall ∆r G. The ranking also takes into account the number of enzymes that are
native in a specified host organism. Pathways with less heterologous enzymes are preferred
as they potentially require less genetic engineering work in the practical implementation.
The last ranking criterion counts the number of different cofactor species that are required
by a pathway candidate. Cofactors are often expensive and require regeneration which can
be difficult to implement. Thus, pathway candidates with less cofactors are preferred.
In addition to the output of the reactions of each pathway candidate and an overall balance
of each reactant in a pathway, further information useful for their assessment is given. The
thermodynamic profile allows for a quick visual assessment of each pathway. An SBML
(HUCKA et al., 2003) file containing all reactions on the pathway allows the visualization of
the path and the active reactions with any tool capable of reading SBML (e.g. Cytoscape
(SHANNON et al., 2003; SMOOT et al., 2011)). A list of possible side reactions for each
pathway candidate in a given host organism can help to find pathways with a small number
of side reactions or even identify those side reactions that can be deleted.
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Computational Details
Our path-finding tool is implemented in MATLAB© R2015a (8.5.0) (MathWorks). As a MILP
solver we used the IBM CPLEX Optimizer 12.5. All data from KEGG is obtained using the
KEGG REST API. The eQuilibrator 2.0 source code was cloned from the GitHub repository of
component-contribution 1. The computations were carried out on a 64bit, 3.4Ghz Intel Core
i7-2600 PC with 8 GB RAM.
All data generated or analyzed during this study are included in this part and Appendix A.
The software used in this study is available for download at https://doi.org/10.5281/
zenodo.816174. The most recent version can be found at our github repository https:
//github.com/mecatsb/mecat.
4.3 Results
We use GPP as a first example to illustrate features of our method. GPP is part of the
metabolism of most organisms and plays a key role in the terpenoid biosynthesis. Its
precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) can
be synthesized via two different pathways. The mevalonate pathway starting with acetyl-CoA
is present in fungi, archaea and some bacteria. The non-mevalonate pathway (MEP/DOXP
pathway) with pyruvate as a precursor exists in plants, eubacteria and protozoa (MICHAL
et al., 2012). From the computed pathways we chose interesting candidates depicted in
Figure 4.4 and 4.5.
The pathway candidate in Figure 4.4 corresponds to the lower mevalonate pathway. It starts
with 2-oxoglutarate synthesizing IPP and DMAPP in seven consecutive reactions plus an
additional reaction to GPP. The pathway candidate has 11 potential side reactions which
are provided in more detail in the Appendix Section A.1. These reactions can potentially be
active in permeabilized cells or cell lysates but might be disrupted by corresponding gene
deletions. If a synthetic mixture of enzymes of interest would be applied, these reactions
would not be active at all. With the presented network we were also able to recover the
non-mevalonate pathway shown in Figure 4.5. The thermodynamic profiles for the linear
path of these pathways are shown in Figure 4.6 and 4.7. They indicate that the operation of
these pathways is thermodynamically feasible with negative and constantly dropping ∆r G.
Our tool proposes 11 potential side reactions for the mevalonate pathway and 24 for the
1 https://github.com/eladnoor/component-contribution, cloned on 20.02.2016


































Figure 4.4: Pathway candidate 1. Synthesis of geranyl pyrophosphate via the mevalonate
pathway.
non-mevalonate pathway. They are provided in more detail in the Appendix Section A.1. The
candidate for the mevalonate pathway was chosen because of its favorable thermodynamic
profile (Figure 4.6) with a large drop of ∆r G in the last two reactions. This final drop has
the potential to lead to high conversion. Additionally, all substrates for the synthesis are
readily available. However, the mevalonate pathway is not natively present in our chosen
host E. coli. The second pathway candidate based on the non-mevalonate pathway displays
an alternative method for the production of GPP, which is fully present in E. coli.
We chose amygdalin as a further example. In this case, we added sucrose as a potential
starting and basis metabolite. Sucrose is excluded from the original set of starting metabolites
because of its higher molecular mass but is much cheaper than α-D-glucose 6-phosphate.













































Figure 4.5: Pathway candidate 2. Synthesis of geranyl pyrophosphate via the non-mevalonate
pathway.
active reactions to amygdalin. The first candidate starts with sucrose and the second with
α-D-glucose 6-phosphate.
Both candidates require a uridyl moiety as substrate. Nevertheless, in the search carried out,
uridine 5’-triphosphate (UTP), uridine 5’-diphosphate (UDP) and uridine 5’-monophosphate
(UMP) were considered cofactors to avoid unnecessary interconversion of nucleotides that
would add numerous but not meaningful pathway candidates. And in both candidates,
two of the reactions are catalyzed by heterologous enzymes. For the first pathway, four
potential side reactions are proposed and five for the second. These pathway candidates
highlight the impact of the list of potential starting metabolites on the results. While both
pathways look promising, the first one starts with the cheap starting substrate sucrose and
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Figure 4.6: Thermodynamic profile for the mevalonate pathway.
has a better thermodynamic profile. In an industrial environment it would be advisable to
create a customized list of starting metabolites considering more criteria, e.g. of cost and
availability.
Another example is pyrrolysine. The selected pathway candidate has four active reactions
and starts with L-Lysine as substrate. Thermodynamic data for this pathway is not available
in eQuilibrator. In E. coli, this pathway does not exist, but it is native in methanogenic
archaea. The pathway requires ATP and NAD+/reduced nicotinamide adenine dinucleotide
(NADH) as cofactors. It has nine potential side reactions.
As a last example, we chose (S)-2-phenyloxirane. The selected pathway candidate for (S)-2-
phenyloxirane has four consecutive active reactions. It uses cinnamaldehyde as substrate
and requires CoA, NADP+/NADPH and AxP as cofactors. The thermodynamic profile is
not ideal with regard to the first and last reaction steps that both have a slightly positive
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Figure 4.7: Thermodynamic profile for the non-mevalonate pathway.
∆r G. Potentially, the last step could be promoted by an efficient reduced flavin adenine
dinucleotide (FADH2) regeneration or oxygen supply pushing the equilibrium to the product
side. However, it remains questionable if FADH2 can be regenerated in permeabilized cells.
Details to all examples shown are given in the respective sections of the Appendix Section
A.1. The Appendix Section A.2 contains details on the computation times of all examples.
4.4 Discussion
We presented a method for searching potential synthesis pathways for target metabolites
without the specification of a fixed starting point. Due to the nature of the search algorithm,
the resulting pathway candidates are unbiased by the user’s knowledge and expectation of
the most suitable pathway. Our method leads to a large number of results in a broad solution
space which may make it challenging to find the most appropriate candidate. Handling
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this amount of data requires a sophisticated tool of filtering, ranking and expert assessment
together with additional features such as the quick evaluation of potential side reactions and
thermodynamics. Altogether, our tool is highly customizable and offers flexible filtering and
ranking options. All metabolite lists, especially the metabolite pool can be easily adapted to
meet the needs of a specific project. This is especially useful in cases where the metabolite pool
should be composed of chemicals of the laboratories’ inventory or of inexpensive chemicals.
Analogously, all ranking or filtering criteria can be tailored to the focus of the study, such as
reagent costs or a specific host organism.
Expert knowledge to assess the pathway candidates is still needed. However, the same
applies to any pathway design method available to date. The resulting pathway candidates
depend fully on the data used to set up the network. The sheer mass of reactions in KEGG
makes errors hard to identify manually, and we did not carry out any data cleaning except the
measures discussed in section 4.2 Network Reconstruction. Crude errors such as unbalanced
or ill-formed reaction entries in KEGG were automatically identified and excluded from our
network.
Thermodynamics of a pathway is complex. Most substances involved in a pathway are not
present at the beginning but are rather formed as the synthesis proceeds. This is not taken
into consideration. We fix the initial starting concentrations of all metabolites to 1 mM.
However, these can be easily modified by adapting the respective values for the calculation of
the ∆r G in eQuilibrator. Note, that all ∆r G are estimated using the component contribution
method. They can however be replaced by experimental values, if available.
We do not consider enzyme concentrations or any kind of kinetic parameters such as enzyme
turnover numbers or Km values. While this would be a relevant addition, to our knowledge
this information is not readily available on the scale needed for large networks. It could
however be integrated for smaller networks, e. g. (KHODAYARI et al., 2016), particularly in
the ranking procedure.
4.5 Conclusions
The presented method provides a helpful computational tool for the directed design of biosyn-
thetic production pathways and the planning of syntheses. The tool provides a very useful
basis for the eventual selection of pathways to be implemented in the wet lab. Building on this,
expert knowledge is required to tackle possible practical problems with the implementation
of the most promising candidates. All features presented are autonomous. The generated
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thermodynamic profiles of pathways are invaluable for selecting the most promising pathway
alternatives. Similarly, computing potential side reactions leads to important insights for all
kinds of pathways.
In different use cases different ranking criteria may be considered important. The user of the
tool can easily select or define own criteria for ranking results. For the synthesis with cell
lysates or permeabilized cells, the consideration of heterologous enzymes and the choice of
the most suitable host as well as potential side reactions are certainly very important.
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Abstract
Cell-free systems containing multiple enzymes are becoming an increasingly interesting
tool for one-pot syntheses of biochemical compounds. To extensively explore the enormous
wealth of enzymes in the biological space, we present methods for assembling and curing
data from databases to apply them for the prediction of pathway candidates for directed
enzymatic synthesis. We use KEGG to establish single organism models and a pan-organism
model that is combining the available data from all organisms listed there. We introduce a
filtering scheme to remove data that are not suitable, e.g. generic metabolites and general
reactions. Additionally, a valid stoichiometry of reactions is required for acceptance. The
networks created are analyzed by graph theoretical methods to identify a set of metabolites
that are potentially reachable from a defined set of starting metabolites. Thus, metabolites
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not connected to such starting metabolites cannot be produced unless new starting metabo-
lites or reactions are introduced. The network models also comprise stoichiometric and
thermodynamic data that allow the definition of constraints to identify potential pathways.
The resulting data can be directly applied using existing or future pathway finding tools.
5.1 Introduction
The enzymatic potential of the numerous enzymes in nature is a most promising, extremely
versatile and powerful resource for creating powerful tools for the production of various
interesting products. Besides the production in host organisms, synthesis using cell-free sys-
tems gains more and more interest. Particularly multi-step biocatalysis seems only marginally
explored today compared to its expected huge potential (HEINZLE et al., 2013). Cell-free
systems for the synthesis range from mixtures of isolated enzymes over multi-enzyme systems,
e.g. multi-enzyme complexes (S.-Z. WANG et al., 2017) and enzyme cascades, to cell lysates
(ENDO et al., 2001) and permeabilized cells. In special cases such systems are even combined
with chemical synthesis in one pot (GROEGER et al., 2014).
The design of a multi-step synthesis route does not only require the determination of the
reaction sequence leading to the desired product, but also depends on numerous aspects such
as substrate and cofactor supply or thermodynamics. For living cells, a recent review article
discusses the state of the art computational tools for design and reconstruction of metabolic
pathways (L. WANG et al., 2017). To design such a pathway for cell-free biosynthesis is by
far not developed to such a mature state. In particular, it seems almost impossible to explore
manually all potentially feasible pathways and to determine which one is the most suitable
for production.
The in silico path-finding and design methods all require a metabolic network model contain-
ing all required information from the host organisms of interest, such as enzyme, reaction
and thermodynamics data. There is an ever-growing plethora of biological databases with
enzyme and reaction data of an ever-growing number of organisms that is suited for the
reconstruction of genome scale metabolic networks. One of the most popular databases is
KEGG (KANEHISA, FURUMICHI, et al., 2016; KANEHISA et al., 2000; KANEHISA et al., 2018).
However, despite the huge amount of data collected from primary literature that is carefully
curated afterwards, the data is partly incomplete, and sometimes even inconsistent or er-
roneous. It is thus a challenge to handle this data and make it suitable for useful network
reconstructions.
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We already presented a computational tool to guide and support finding the most suitable
synthesis path to a product (BLASS et al., 2017). We extended this work by developing a
method of building network models from KEGG data which is suitable for path-finding. We
selected nine organism networks that are of interest primarily for their application in cell-free
production. Some were selected because of peculiarities of the networks. Finally, a so-called
pan-organism network was used lumping all metabolic reactions listed in KEGG in one single
network.
5.2 Materials and Methods
In the following we give a short introduction to our path-finding method. We also present
how to build network reconstruction models based on data found in biological databases,
particularly KEGG.
Path-finding
We already presented a method for finding candidates for suitable synthesis pathways in
genome-scale metabolic network reconstructions starting from arbitrary substrates (BLASS
et al., 2017). A pathway in our definition consists of two parts. First, the so called linear path
consists of a sequence of metabolites connected by reactions. It starts with a reaction that
has one of the possible predefined start metabolites as a substrate and ends with a reaction
that has the target metabolite T as a product. Second, there is the set of supplying reactions,
which provide the substrates required by the reactions on the pathway that are not contained
in the metabolite pool. All metabolites in this pool are considered freely available since they
will be provided by the specified pathway reactions (see Section 5.2 Model Building).
The path-finding algorithm is based on a MILP and combines graph-based path-finding and
reaction stoichiometry (PEY et al., 2011). The method is elaborated in detail in (BLASS
et al., 2017). Figure 5.1 shows an exemplary pathway illustrating a possible solution of the
MILP. The pathway shown is a feasible synthesis pathway to the target T (depicted as red
octagon). Metabolites in the figure are depicted as squares, where large squares represent
metabolites in arcs (see 5.2 Model Building) and small squares represent cofactors and
inorganic metabolites. Reactions are represented by circles. The linear path of the pathway
is marked with a blue background. Metabolites S1 to S4 and M1 (marked in green) are
contained in the metabolite pool (see 5.2 Model Building) and are thus initially available. As
M4, which is required by reaction R3, is not available from the metabolite pool, R4 is needed
as a supplying reaction producing it.







Figure 5.1: Exemplary pathway illustrating a feasible pathway to the target metabolite T
(red octagon). Large squares: metabolites with arcs (see 5.2 Model Building); small squares:
cofactors/inorganic metabolites; green: metabolites from the metabolite pool (see 5.2 Model
Building); circles: reactions; blue background: linear path; R4 : supplying reaction.
In addition to the 17 constraints of the MILP presented in (BLASS et al., 2017) we added a
constraint which prevents the use of a reaction in the pathway (more precisely, the supplying
reactions) that consumes the target. This constraint is necessary to prevent cycles formed by
a reaction belonging to the linear path that produces the target and a supplying reaction
consuming the target to produce a precursor which is consumed by a reaction on the linear
path. It thus prevents pathways for which the target has to be already present in at least
catalytic amounts. An example for such an undesired pathway is shown in Figure 5.2. In this
example, the target T needs to be consumed by reaction R6 to form metabolite M4 which is
required by reaction R5 to produce the target T.
The complete MILP is listed in Appendix Chapter B.1.
Model Building
In the following, we define the different parts of our network reconstruction and model
based on KEGG data. The reactions and metabolites in the model are given as lists of KEGG
REACTION and COMPOUND ids (KANEHISA, FURUMICHI, et al., 2016). The reactions and
metabolites are connected by arcs, which are derived from reactions.







Figure 5.2: Exemplary pathway illustrating a pathway to the target metabolite T (red octagon)
where T needs to be consumed in order to produce M4. Large squares: metabolites with arcs;
small squares: cofactors/inorganic metabolites; green: metabolites from the metabolite pool;
circles: reactions; blue background: linear path; R4 is a supplying reaction. This pathway
example is not a valid synthesis pathway candidate for T.
The metabolites in the model are categorized into sets that are treated differently in the path-
finding algorithm. One set consists of potential start metabolites. These are all metabolites in
the model that can be used as the start of the linear path of a pathway candidate. Metabolites
in this category are automatically determined and have a molecular mass smaller than 300
and occur in arcs. The so called basis metabolites are expert-curated metabolites which
are inexpensive, easily available and are often hubs in the arc network, such as D-glucose
(C00031) or pyruvate (C00022). The cofactors (e.g. ATP (C00002), NADH (C00004) etc.)
and inorganics such as water (C00001), oxygen (C00007) or CO2 (C00011) are a set of
expert-curated metabolites that are considered as freely available if they are required as
substrates in reactions, but are not part of the reaction chain. They are thus excluded from
the arcs to prevent biologically meaningless shortcuts in the pathways. All metabolite sets
are disjoint, except for the basis metabolites that form a subset of the start metabolites. The
metabolite pool is the superset of metabolites that are considered as freely available. It is
made up of start metabolites, basis metabolites, cofactors and inorganic metabolites. Further
details on the different categories are given in Section 4.2 Network Reconstruction.
For each reaction there is a set of arcs, which are substrate-product pairs of a reaction. There
are different strategies to derive the arcs from a reaction. The straightforward method
is using all possible combinations (i.e. the cross product) of substrates and products of
a reaction. It is however more useful to use meaningful substrate-product pairs, such as
reactant pairs. A reactant pair is a substrate-product pair with both parts having atoms or
atom groups in common that preserves the chemical substructures of the reactants through
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the reaction (KOTERA, HATTORI, et al., 2004; KOTERA, OKUNO, et al., 2004). The reactant
pairs are defined in the KEGG RCLASS database, which classifies reactions based on the
chemical structure patterns of their substrate-product pairs (MUTO et al., 2013). Only those
reactant pairs are used for the arcs that do not contain any metabolite from the cofactor and
inorganics list. This means, however, that reactions involving metabolites from this list are
still represented by the remaining arcs. A more detailed discussion on the arcs can be found
in Appendix B.2 (Tables B.12 to B.16). The arc graph of the model is a directed graph G = (V,
E), where V is the set of metabolites and E is the set of arcs between these metabolites. The
model also contains a stoichiometric matrix, where each row corresponds to a metabolite in
the model and each column indicates a reaction. An entry in the matrix is the stoichiometric
coefficient of the metabolite in the respective reaction.
When using KEGG COMPOUND and KEGG REACTION data for a network reconstruction
some obstacles have to be addressed. One of them is reaction directionality. For the reactions
contained in KEGG the reaction directions are not indicated in the database entries. There
is thus a need for further reaction data to annotate directionality. To do so, we use the
component contribution method of the biochemical thermodynamics calculator eQuilibrator
(FLAMHOLZ et al., 2012; NOOR et al., 2013) to compute the ∆r G
′m value (the change of the
Gibbs free energy of a reaction at a given pH of 7 and ionic strength I in 1 mM concentration
of the reactants) for each reaction in the network and infer if the respective reaction is
reversible. Reactions with |∆r G| ≤ 15 kJ/mol are designated as reversible. In biological
systems as well as in most biosynthetic setups concentrations of substrates and products often
differ by several orders magnitude. This significantly influences reaction reversibility. As
these effects cannot be adequately considered given the size of the networks presented in this
work and the unknown kinetics, the∆r G value of 15 kJ/mol was chosen as a consensus value
to determine reaction reversibility. This somewhat arbitrary value represents a compromise
between the assumption of reversibility of all reactions and a more stringent restriction with a
∆r G value of less than 15 kJ/mol that would potentially exclude feasible biosynthetic routes
with concentrations of intermediates adjusting in a running system. The value was set after a
series of simulations and expert inspection of results. However, the user of our tool can freely
set the ∆r G cutoff to meet the needs of his specific investigation. The reactions are added
to the model in the respective direction(s), which means that for each reversible reaction
we get two reactions in the respective directions. Another obstacle is the inconsistent use of
identifiers for metabolites. In some reaction equations, the KEGG COMPOUND (C) identifiers
are used and in others the G identifiers from the KEGG GLYCAN structure database. As we
do not consider glycans, those reactions are excluded. For polymerization reactions, the
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reaction stoichiometry in KEGG is not expressed in distinct numbers. Such reactions are not
applicable for our method where the coefficients in the stoichiometric matrix are required to
be integer numbers.
We did not generally exclude membrane associated reactions. To our knowledge it is not
sufficiently clear whether and to which extent intracellular as well as extracellular membrane
associated enzymes are active in permeabilized cells. In earlier work we could, however,
experimentally show that megasynthases producing a circular oligopeptide can be kept active
in permeabilized cells in contrast to cell extracts where activities could not be detected
(WEYLER et al., 2017). The exact reasons were not identified but could potentially be related
to yet unknown membrane association. On the other hand, in selectively permeabilized
eukaryotes, the organelles including membrane reactions remain intact and functional (e.g.
(NICOLAE et al., 2015)).
We thus have to filter the KEGG data before building a model. Figure 5.3 shows the filtering
steps to obtain the reactions suitable for building a reconstruction of a pan-organism network
encompassing reactions from all organisms and also for organism-specific networks.
The filtering starts with all 11196 reactions in KEGG REACTION. First, the reactions with
invalid reactants are removed, which are reactants that do not have a C identifier. The 10764
remaining reactions are further trimmed down to 10603 reactions with valid stoichiometry,
where all reactants have integer stoichiometric coefficients. From these, reactions that are
generic or contain generic reactants (i.e. the database entry has a comment containing
’generic’, ’incomplete’ or ’general’) are removed, sparing 7989 reactions. After removing
those without any reaction class annotations, 7676 reactions remain in the pan-organism
model, which corresponds to about 69 % of all KEGG reactions.
To build the organism-specific models, the organism annotation for the genes of the enzymes
catalyzing those reactions is used. From the 7676 reactions in the pan-organism network
reconstruction, KEGG has EC numbers associated with 5975 reactions. 4549 (76 %) of them
have enzymes whose genes are annotated with organisms. These reactions are the basis of
the organism-specific network model reconstructions. Our network reconstruction workflow
filters out ill-formed reaction entries in KEGG. However, we do not include a gap filling step.
This would require large manual efforts that are not in the scope of this work.
Possible target metabolites in KEGG for the computation of synthesis pathway candidates are
determined automatically. A target metabolite is a metabolite in the respective model that is
not a dedicated start or basis metabolite. It also has to appear as a product in at least one
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Figure 5.3: Reaction filtering from all reactions in KEGG to the set of reactions for building
the pan-organism network reconstruction and the organism-specific models. The reactions are
filtered in the given order. The numbers indicate how many reactions stay after filtering. The
width of the box bases are proportional to the number of reaction that remain after filtering.
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arc in the network, so it could be potentially produced. We predict potentially producible
targets in a given model by determining its feasible reactions, i.e. reactions for which
potentially all substrates are available or producible. The feasible reactions are obtained by
initially starting with the set of metabolites consisting of the model’s start metabolites and
cofactors/inorganics. With these metabolites, all reactions that are feasible are determined
by checking for each reaction that has not already been added to the set of feasible reactions
if all substrates are available. The products of these feasible reactions are added to the set of
metabolites. This step is repeated until no new substrates are added. The resulting set of
reactions is then a subset of the model’s reactions that potentially are feasible.
The next step is to do a reachability screening in the arc graph of the model. To do so, we
add a node representing an artificial start metabolite that is connected to all potential start
metabolites. From there, we do a breadth-first search (BFS), which is a suitable algorithm
for exploring a graph. The search starts with a source vertex and discovers all neighboring
vertices with the present depth before discovering the next depth-level vertices (CORMEN
et al., 2009). The potentially producible targets are those targets that are connected with
the start node by a path (a sequence of edges that connect vertices) and that are produced
by any of the feasible reactions.
Computational Details
The model data is based on KEGG release 90.1, May 1, 2019. The code for model building
and statistics is written in Python 2.7, the code for the thermodynamics is written in Python
3.6 using the eQuilibrator API (FLAMHOLZ et al., 2012). We furthermore used the packages
graph-tool (PEIXOTO, 2014) and Matplotlib (HUNTER, 2007). The path-finding tool was run
on MATLAB R2019a with IBM CPLEX Studio 12.9. All computations were carried out on an
Intel Core i7 with 2.5 Ghz and 32 GB RAM.
The software used in this study is available at https://github.com/mecatsb, where the
repository mecat contains the path-finding tool and the repository mecatpy contains the
code used for the pathway analysis as well as the organism models. Release v1.0 contains
the code version used in this study.
5.3 Results
We first present the organisms and models used in our study and then discuss some interesting
properties of these models. We finally present and discuss the results of our path-finding
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analysis.
Models
For each organism in the KEGG Organisms database we build an organism-specific network
model as described in Section 5.2 Model Building. Figure 5.4 shows the number of reactions
in KEGG that are annotated for the specific organism together with the number of reactions
that are part of the organism-specific network reconstruction. The organisms are sorted
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Figure 5.4: Comparison of the total number of reactions and the number of reactions selected
for the models for all organisms annotated in KEGG.
in descending order with respect to the number of annotated reactions in the model. The
order in which the reactions are filtered is following the procedure shown in Figure 5.3. On
average 67 % of the reactions in KEGG that are annotated with an organism end up in an
organism-specific model (see insert in Figure 5.4). The reason for this is the filtering of all
reactions according to the filter constraints shown in Figure 5.3 and discussed in detail in
Section 5.2 Model Building. Figure 5.3 shows that the majority of the discarded reactions
are general and/or generic or contain generic reactants.
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In addition to the pan-organism network model we chose nine organism-specific models
for all network and pathway analyses as examples. Table 5.1 lists the organisms, which
were chosen primarily for their importance in biotechnological production as well as in
scientific research. CHO, the permanent cells of the ovary of a Chinese hamster C. griseus
Table 5.1: Models for the studies. The model names are derived from the KEGG organism codes,
except for the pan-organism network model which is named kegg. The number of reactions in
KEGG refers to the number of reactions that are annotated for the respective organism. The
number of reversible reactions is the corresponding subset of the reactions in the model. The
feasible reactions are determined as described in Section 5.2 Model Building based on the set of
basis metabolites as start metabolites. The basis metabolites are selected as described in Section
5.2 Model Building.
model name reactions (KEGG /
model / reversible)

































were originally isolated already in 1957. CHO is serving as a model cell line for metabolic
studies. Most importantly, however, it is most frequently used for the industrial heterologous
production of therapeutic proteins (LALONDE et al., 2017; WURM, 2004). The application
of animal cells for biosynthetic purposes is easier starting from cell lines like CHO rather
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than cells from primary tissues. E. coli is probably the most important model organism and
is used in all kinds of areas spanning from basic molecular biological work to industrial
applications (PONTRELLI et al., 2018). V. natriegens is an extremely fast growing marine
bacterium that recently got increasing interest. Due to its duplication time of ten minutes
it has been in the focus of molecular biology research, e.g. for protein production also in
cell-free systems (FAILMEZGER et al., 2018; HOFFART et al., 2017). P. putida is known for its
diverse biodegradation and biosynthetic capabilities (LOESCHCKE et al., 2015; NIKEL et al.,
2016; POBLETE-CASTRO et al., 2012). M. xanthus is a model organism for studying social
behavior of bacteria with extended signaling networks and secondary metabolite production
(WRÓTNIAK-DRZEWIECKA et al., 2016). S. cerevisiae is probably the most important eukaryotic
model microorganism used very widely and already for a long time for the production of
ethanol in alcoholic beverages and biofuel. It is also widely discussed for the production of
other metabolites and its broad application is supported by a large toolbox for metabolic
engineering (KRIVORUCHKO et al., 2015; NIELSEN, 2019; STEENSELS et al., 2014). The yeast
S. pombe is a model organism primarily used in molecular and cell biology but is recently also
discussed as promising candidate for the expression and secretion of heterologous proteins
(TAKEGAWA et al., 2009). C. glutamicum is a most important microorganism in the industrial
scale production of amino acids but also other metabolic products (BECKER et al., 2016).
While these organisms have been used in a vast range of production processes they are also
well understood and we assume that KEGG data on these organisms is relatively complete
and accurate. M. penetrans has the smallest genome of known organisms and its metabolism
is very limited (SASAKI et al., 2002). From the present view, the most important organisms
for cell-free synthesis are E. coli, S. cerevisiae, P. putida and M. xanthus. All model data is
part of the GitHub repository https://github.com/mecatsb/mecatpy. We exclude plants
and algae from our species models since they seem less applicable from the present view on
cell-free biocatalysis.
Table 5.2 shows the number of potential targets for the respective model as defined in Section
5.2 Model Building. The arc reachable targets are those targets that are connected to a basis
metabolite via an arc path, which is determined by BFS. The feasible targets are targets that
are products of feasible reactions as described in Section 5.2 Model Building. The set of
potentially producible targets is the intersection of the targets that are connected to a basis
metabolite via an arc path and the targets that are products of the feasible reactions.
Table 5.2 shows that a large portion of potential targets is not connected to any of the basis
metabolites in the model. For all models, about 32% (in the S. pombe model spo) to 43% (in
the pan-organism model kegg) of all potential targets are potentially producible targets. This
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Table 5.2: Number of potential targets for each organism model based on basis metabolites as
possible start metabolites. Arc reachable targets: targets that are connected to a basis metabolite
via an arc path; feasible targets: targets that are products of feasible reactions as described
in Section 5.2 Model Building; potentially producible targets: targets that are connected to a
basis metabolite via an arc path and that are products of feasible reactions and are thus realistic
targets, intersection of the former two columns of the table; % of potential targets: percentage












kegg 5441 3017 2412 2325 43%
cge 1128 437 358 333 30%
eco 878 419 376 351 40%
vna 865 397 348 328 38%
ppun 902 380 317 293 32%
mxa 777 320 281 266 34%
sce 713 268 243 227 32%
spo 637 264 216 201 32%
cgb 598 261 215 200 33%
mpe 184 70 69 56 30%
means that for all other potential targets a synthesis pathway cannot be found, as a path is
a required part of a valid solution. We will elaborate the reasons for this drastic reduction
later in this work.
Network Model Analysis
We first present some basic properties of the arc graphs of the different organism models.
Figure B.1 in Appendix B.2 shows the node degree distributions of the arc graphs of the
different organism network reconstructions. The degree of a node is the number of edges
leaving it (out-degree) plus the number of edges entering it (in-degree). Tables B.1 to B.10
in Appendix B.2 list the hubs with the top 5 occurrences of each network. As expected,
pyruvate, L – glutamate, D – glyceradehyde3-phosphate and acetyl-CoA are in almost all cases
metabolites with highest node degrees. M. penetrans (mpe), having the smallest network of
all studied here, differs most significantly from all others both in the types of metabolites with
highest node degrees as well as in the generally small numbers of node degrees (< 13). In the
pan-organism network model (kegg), trans,trans-farnesyl diphosphate has an exceptionally
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high node degree (107) that is, however, mostly originating from plant metabolism. In kegg,
pyruvate is by far the most connected metabolite with a node degree of 167. The outstanding
role of only a few metabolites is most strikingly seen in Figure B.1 of Appendix B.2. The
sizes of the arc graphs together with the average node degrees, standard deviation of the
distribution are listed in Table B.11 of the Appendix Section B.2. It is interesting to see that
the average node degrees vary only from 2.37 to 3.14 for individual organisms and 3.3 for
kegg, the pan-organism network.
Table 5.3 lists the number of connected components of the arc graphs in the respective models
and the size of the largest connected component, respectively. A connected component in
Table 5.3: Number of components in the models with the number of metabolites in the largest
component. The fourth column lists the number of components containing basis metabolites.
The last column shows the number of metabolites that belong to a component containing basis
metabolites. The percentage of those metabolites in relation to the number of metabolites in the










kegg 481 4612 1 4612 (74%)
cge 186 754 4 763 (55%)
eco 139 766 2 768 (69%)
vna 146 726 1 726 (66%)
ppun 157 761 2 763 (66%)
mxa 159 587 3 595 (60%)
sce 182 478 1 478 (50%)
spo 162 438 1 438 (52%)
cgb 115 457 2 459 (60%)
mpe 57 76 7 141 (54%)
the graph is a subgraph where each vertex in the subgraph is connected to each other vertex
in the subgraph by a path (CORMEN et al., 2009). The smallest connected components
contain 2 vertices in all models. This is by definition the smallest component size as the
arc graph does not contain metabolites without any arcs. We furthermore list the number
of components containing basis metabolites; as well as the total number of metabolites in
all those components with the percentage of those metabolites in relation to the number of
metabolites in the arc graph (in parentheses). These numbers give information on how much
of each network is possibly reachable from the designated start points, since a potentially
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producible target has to be connected to any of the predefined basis metabolites via an
arc path. Table 5.3 shows that between half and two third of the metabolites in a model’s
arc graph are contained in a component with basis metabolites. Exemplarily, Figure 5.5
shows the arc graph of the pan-organism model kegg. The arc graph consists of a large main
Figure 5.5: Arc graph of the pan-organism model kegg. Red: components containing potential
start metabolites; blue: satellite components without start metabolites.
component and a large number of small components. Components in red are components
containing potential start metabolites, whereas the components in blue are so called satellite
components without start metabolites. The arc graphs of the other models are shown in
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Figure B.2 of Appendix B.2. Figure B.3 of Appendix B.2 shows the arc graph component
histograms.
There are several reasons for isolated components in a model. The first reason is missing
annotation in the data on which the model is based. This could be improved by using manually
compiled and curated network reconstructions with gap filling. Several reactions in KEGG
are formulated as general reactions and/or are reactions containing generic compounds.
Some of the often numerous reactions summarized in such reactions are explicitly listed in
KEGG. An even larger number could in principle be added e.g. from BRENDA (JESKE et al.,
2018). Some reactions involve additional proteins that transfer electrons or groups or use
covalently bound cofactors as e.g. NAD(P)H. These are filtered out in the model building
process. As we do not include such reactions in our model, some metabolic pathways could
be cut off. Another reason is that a component is really isolated.
In the Supplementary Information 3 of (SCHUH et al., 2019) we list all components identified
in the kegg model. The 6246 metabolites are grouped in 481 components. The largest
component connected to start metabolites comprises 4612 metabolites and is represented in
the center of Figure 5.5. All other components with a size of 5 or more metabolites were
investigated in more detail (Supplementary Information 4 of (SCHUH et al., 2019)). They
comprise 682 metabolites in 69 components. We could identify some typical families related
to biochemical characteristics (Appendix B.3). Reactions of xenobiotic compounds, e.g. drugs,
were most prominent with 14 components with 141 metabolites followed by polyketides
(10/109), carbohydrate derived metabolites (10/86), terpenoids (9/112), compounds with
gonane tape nucleus (7/74), fatty acid and lipids related compounds (7/59) and flavonoids
(4/54). Xenobiotics are inherently not listed in the starting metabolites. Some of these
families have often general reactions or involve generic metabolites, e.g. metabolites contain
a group -R that is not explicitly specified. R is later cleaved off the metabolite. Smaller
components (< 5) were not analyzed in detail but could often serve as missing links in larger
pathways once the connecting reactions could be defined following the criteria specified in
5.2 Model Building.
Reachability Analysis
We determined the target reachability in the pan-organism network and the organism-specific
networks by testing the existence of a pathway candidate to each possible target starting with
basis metabolites using our MILP presented in Section 5.2 Path-finding. Figure 5.6 shows
for each model the percentage of targets for which a synthesis pathway candidate has been
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not found (connectivity - satellite components)
not found (connectivity - components with start metabolites)
not found (feasibility)
not found (other)
Figure 5.6: Analysis of the target search in the different organism models. Blue: targets for
which a pathway candidate has been found by our method, but that have not been predicted as
feasible; orange: targets for which a pathway candidate has been found by our method; green:
targets for which a candidate has not been found due to the absence of an arc path from any start
metabolite to the target because the target is in a satellite component without start metabolite;
red: targets for which a candidate has not been found due to the absence of an arc path from
any start metabolite to the target (and the target is in a component with start metabolites);
purple: targets for which a candidate has not been found due to the lack of a feasible reaction
that produces the target; brown: targets for which a candidate has not been found due to other
reasons that are discussed in the text.
the figure is listed in Table B.17 of Appendix B.2. In the following, we discuss the different
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fractions in more detail.
The blue and orange fractions represent the targets for which a synthesis pathway candidate
has been identified in the respective models. The targets represented by the orange fractions
have been predicted to have a pathway candidate. This means that they can be produced
by feasible reactions of the model and they are connected to at least one of the predefined
basis metabolites by a path in the arc graph (see Section 5.2 Model Building). An example
for this category is UDP-glucose (Chapter 6 Synthesis Paths for UDP-glucose). However, the
targets represented by the blue fractions have not been predicted to be feasible, despite
having a synthesis pathway candidate. For those targets we found that most of the pathway
candidates calculated with the MILP include a direct cycle formed by supplying reactions
that use metabolites that are not in the metabolite pool. In a mathematical sense, it is
valid to consume a metabolite as long as its overall balance is zero. However, in real world
applications, this would not be correct since the metabolite has to be present in at least
catalytic amounts already at the start of the reaction. An example for such a pathway is the
pathway candidate for the 5-methyl-5,6,7,8-tetrahydromethanopterin (C04488) production
in the pan-organism network model kegg (Appendix B.4). The pathway requires coenzyme
F420 (C00876) and reduced coenzyme F420 (C01080), which are neither metabolites nor
cofactors and thus are not part of the metabolite pool. They thus have to be produced by the
reactions of the pathway.
The green, red, purple and brown fractions represent targets without any pathway candidate.
In the following, we will discuss the different reasons for this. With the help of BFS, we
found that the targets represented by the green and red fractions are not connected to any
of the potential start metabolites via an arc path. Therefore, these targets cannot have a
pathway candidate, since a path from a start metabolite to the target is mandatory, as stated
in Section 5.2 Path-finding.
The targets belonging to the green category are not part of a component containing potential
start metabolites. In our pan-organism model kegg, this is the case for proansamycin X.
Component 134 in Supplementary Information 4 of (SCHUH et al., 2019) shows that there is
no reaction in KEGG producing proansamycin X (C12176) from 3-amino-5-hydroxybenzoate
(C12107), which belongs to a component with start metabolites (Supplementary Information
3 of (SCHUH et al., 2019)). The situation could be improved by using manually compiled
and curated network reconstructions with gap filling, e.g. for metabolites of the earlier
discussed polyketide, flavone and terpenoid families (see also Appendix B.3). As outlined in
Section 5.2 Model Building, we only did some minor generic curation which has the purpose
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of extracting meaningful data and removing ill-specified data. A comprehensive network
reconstruction for an organism would require a lot of manual work encompassing more data
sources including primary literature, which was not in the scope for this study. However,
when using our path-finding method, the user can choose any network model that contains
the information needed for path-finding, regardless of data origin.
The targets represented by the red fractions are contained in components with start metabo-
lites but do not have a necessary arc path from a start metabolite to the target, such as
riboflavin (C00255).
The targets represented by the purple fractions are connected to a potential start metabolite
in the network via an arc path. However, this is not sufficient for a valid pathway candidate.
In addition, the arcs have to be associated with reactions for which all substrates are available
or producible to ensure that the pathway candidate is feasible (BLASS et al., 2017). However,
for these targets there is no reaction in the set of feasible reactions (see Section 5.2 Model
Building) that produces that target for the last one arc of the arc path, which means that
the overall pathway is not feasible. Note that the other arc-reaction associations thus do not
matter in this case. An example for such a target is biotin (C00120) (Appendix B.4).
The targets represented by the brown fractions are targets that are predicted to have pathway
candidates as they are connected to predefined start metabolites by an arc path and are
produced by feasible reactions. However, our path-finding algorithm could not determine
valid pathway candidates. To explore the reasons for this, we list the feasible reactions
of the respective models that produce these targets for each of those targets. For each of
these reactions we determine why it is not part of a pathway candidate. We identified
three non-disjoint categories in which we can sort these reactions. To the first category
belong reactions that produce the target but do not have arcs containing the target. As
discussed in Section 5.2 Path-finding, a valid pathway candidate has to include a reaction
with an arc to the target. Reactions that produce the targets only from substrates that are
designated cofactors or inorganic metabolites are also sorted to this category, as they are
correctly predicted to be feasible. However, our path-finding method does not handle such
pathways since a valid pathway candidate requires at least one arc by definition and there are
no arcs containing cofactors and inorganic metabolites. The second category encompasses
reactions that do have an arc to the target, but require a substrate that is also a target for
which no pathway candidate has been identified with our method. The reactions in the
third category cannot be used in a pathway candidate because of a constraint in the MILP,
which excludes pathways that use reactions consuming the target, as discussed in Section 5.2
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Path-finding. There is no valid sequence of reactions with arcs that is feasible without using
supplying reactions that consume the target. An example for a target of the brown fraction
is 5’-methylthioadenosine (C00170), where the reactions producing this target belong to the
first two categories discussed above (Appendix B.4).
To illustrate the different target categories, the example arc graph in Figure 5.7(a) depicts
examples for each of the categories. Note that, for the sake of clarity, the depicted arc graph
has additional vertices for the cofactors (small circles), which would normally not be part of
the graph. The potential start metabolites A and B are depicted by hexagons, the potential
targets E, F, G and H by octagons. Figure 5.7(b) lists the reaction equations and the arcs


























R1 A + B→ C 1,2
R2 B + X→ I 3
R3 C + Y→ E + Z 4
R4 C + X→ D 5
R5 G→ D 6
R6 J→ G 7
R7 D + W→ H 8
R8 I + X↔ D + Y 9,10
R9 L + Z→ F 11
R10 F↔ K 12,13
(b) Reaction definitions
Figure 5.7: Arc graph with examples for the different target categories in Figure 5.6 and the
corresponding reactions. (a): Small circles: cofactor metabolites; hexagons: potential start
metabolites; octagons: potential targets; large circles: metabolites not in any of the previous
categories. Orange: target of the orange category; green: target of the green category; red:
target of the red category; purple: target of the purple category. The numbers on the arcs refer
to the column ’arcs’ in (b). (b): Reactions in the example network with their respective reaction
equations.
R3 (arcs 1, 2 and 4), since all needed substrates, i.e. A, B and Y, are available. E would thus
be a target represented by the orange fractions in Figure 5.6. For target F it is not possible
to find a pathway candidate because F is part of a graph component that does not include
potential start metabolites. F is thus an example of the green fractions. Target G is part of
the component which also includes the potential start metabolites. However, there is no arc
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path connecting metabolites A or B to G, which makes G a target represented by the red
fractions. Target H is an example for the purple fraction. To reach H, there are valid arc
paths (e. g. 1→ 5→ 8 or 2→ 5→ 8), however the last reaction belonging to arc 8 requires
W as a substrate, which is not available.
5.4 Concluding Remarks
Our presented method allows creating and characterizing genome-scale metabolic network
reconstructions for the planning of biosynthetic production pathways using cell-free systems.
The data are taken from biological databases, e.g. KEGG. We also discussed typical problems
in the context of network reconstruction and how these can be solved in order to obtain
applicable network models. We used the presented method for establishing models for the
network reconstruction of a pan-organism from the whole KEGG database as well as for
several interesting model organisms. We also used our path-finding method based on a global
optimization problem to compute pathway candidates for all possible target molecules in the
models and demonstrated that our method yields correct and meaningful results and that it
is widely applicable for all kinds of networks and network sizes. The increasing availability of
larger-scale metabolic networks that are increasingly well curated, as is e.g. already the case
for E. coli and S. cerevisiae (ORTH et al., 2011; ZOMORRODI et al., 2010), will also increase
the power of our method. Our network analysis method for multi-enzyme systems that do
not have any cellular compartments particularly lacking a cell membrane differs significantly
from published methods for whole cells with a defined link to the extracellular environment
via transport systems (von KAMP et al., 2017; S.-Z. WANG et al., 2017) or with models of
microbial communities, e.g. (MAGNÚSDÓTTIR et al., 2018).
The tools we presented are directly applicable to designing the synthesis of target compounds
in cell-free systems. Our analysis tools - especially the feasibility prediction we described
in Section 5.2 Model Building - are useful tools to predict if a target could potentially be
produced in a given model and could thus be used to quickly screen if a host organism or
strain is potentially capable of producing a certain product directly. If this is not the case, a
comparison of biosynthesis pathways in a selected host organism and in the pan-organism is
useful for identifying genetic engineering targets to create a production organism eventually.
Our tools help identifying heterologous enzymes that might be candidates for insertion in
the host organism chosen using genetic engineering to complete a desired pathway in that
organism. Our tools also help to answer which substrates are required for a certain synthesis
pathway.
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Biosynthesis pathway candidates including stoichiometric and thermodynamic constraints
can be determined with our presented path-finding algorithm presented earlier (BLASS et al.,
2017). As reviewed in a recent publication (LIN et al., 2019), various methods have already
been published and are in development that additionally allow the identification of new
reactions considering the promiscuity of many enzymes but also the chemical similarity of
substrates of these enzymes.
Our network reconstructions are the basis for the identification of gaps in the network that
would prohibit synthesis of a desired target. With our tools, it is possible to identify potential
gap fillers from the pan-organism network, which can then be implemented in an organism
of interest using genetic engineering. It is also possible to do manual directed gap filling in
the pan-organism network, e.g. by considering generic reactions, reactions not contained in
KEGG, or expert reasoning.
Overall, our tools and networks are a suitable basis for focused and directed experimental
work and the implementation of the synthesis of target compounds in cell-free systems.
CHAPTER 6
Synthesis Paths for UDP-glucose
In this chapter, the synthesis of UDP-glucose is discussed as an example for the usage of the
presented path-finding tool for the design of synthesis pathways. UDP-glucose is a nucleotide
sugar that plays an important role as an intermediate in various metabolic pathways (RALEVIC,
2015). The path-finding tool is used to computationally search for a synthesis pathway for
the already experimentally shown multi-step synthesis of UDP-glucose from sucrose, UMP,













Figure 6.1: Pathway for the synthesis of UDP-glucose (WEYLER et al., 2015). R00803: su-
crose:phosphate α-D-glucosyltransferase; R00289: UTP:α-D-glucose-1-phosphate uridylyltrans-
ferase; R00156: ATP:UDP phosphotransferase; R00158: ATP:UMP phosphotransferase. Metabo-
lite names in small script denote cofactors or inorganic metabolites.
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pathway consists of two branches. The first branch starting from sucrose via D-glucose-1-
phosphate to UDP-glucose and the second branch starting from UMP via UDP and UTP to
UDP-glucose.
6.1 Model
The pan-organism network model for the design of the synthesis pathway is the same model
that has been used in the experiments discussed in Chapter 5 Network Reconstructions
for Cell-Free Systems with two changes. The first change is the addition of UMP to the
hand-curated list of basis metabolites presented in Section 5.2 Model Building. The second
change is the removal of UTP from the list of cofactors and inorganic compounds to allow
for the synthesis of UTP from UDP.
6.2 Path-Finding and Pathway Candidates
As the longest branch of the experimentally implemented pathway has length three, the
path-finding tool is used to exhaustively find pathway candidates with at most three reactions
on the linear path. The search results in 1203 pathway candidates. Upon inspection of the
candidates, one can observe candidates which involve a direct cycle formed by supplying
reactions that use metabolites that are not part of the metabolite pool and would thus not be
possible in real world applications without the addition of those metabolites to the medium.
Such pathway candidates have already been discussed in Section 5.3 Reachability Analysis
(blue fractions of Figure 5.6). As a global optimization method, the implemented MILP does
not detect such cycles. However, a filter step to remove such pathway candidates has been
developed. The filter takes the set of active reactions of the pathway and the metabolite pool.
It tests for each reaction if all substrates of the reaction are contained in this pool. If this is
the case, the products of the respective reaction are added to the metabolite pool. The active
reactions are tested until no new metabolites are added. If there remain any active reactions
that are not feasible with the substrates of the metabolite pool, the whole pathway is not
feasible and thus filtered from the set of pathway candidates.
After filtering 442 pathway candidates remain. The shortest pathway candidate consists of
two active reactions, while the longest has 39 active reactions. The pathway candidates
have 117 unique linear paths with different supplying reactions. The start metabolites of
the linear pathways are listed in Table 6.1 together with the number of pathway candidates
from the respective start metabolite. The table shows that most pathway candidates start
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with D-glucose (12 candidates), followed by UMP (10 candidates). For sucrose, there are
five pathway candidates.
Table 6.1: Start metabolites of the pathway candidates to UDP-glucose with KEGG ids and the
number of pathway candidates.
start metabolite KEGG id number of pathway candidates
D-glucose C00031 12
UMP C00105 10































The shortest pathway proposed by the path-finding tool that can produce UDP-glucose
from the given metabolite pool is the two-step pathway shown in Figure 6.2. This pathway
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produces UDP-glucose from sucrose, UMP and ATP. The linear path of the pathway is sucrose
→ UDP-glucose (black arrows). UDP is synthesized from UMP and ATP by reaction R00158.









Figure 6.2: Two-step pathway candidate to UDP-glucose from sucrose, UMP and ATP. R00806:
UDP-glucose:D-fructose 2-α-D-glucosyltransferase; R00158: ATP:UMP phosphotransferase. Black
arrows: arcs used on the linear path. Metabolite names in small script denote cofactors or
inorganic metabolites.
Figure 6.3 depicts the second shortest pathway candidate, consisting of three active reactions.
It synthesizes UDP-glucose from sucrose, Cytidine 5’-triphosphate (CTP), orthophosphate
and water. The linear path of this pathway is sucrose → D-glucose 1-phosphate → UDP-
glucose, designated by black arrows. It corresponds to the branch starting with sucrose of
the experimentally shown pathway (Figure 6.1). Reaction R00568 is the supplying reaction
for UTP from CTP and water. The details of this pathway candidate are shown in Listing 2 of
Appendix Section C.1.
The search also proposes a pathway candidate starting from UMP, D-glucose 6-phosphate
and ATP, depicted in Figure 6.4 (details in Listing 3 of Appendix Section C.1). Its linear path
is UMP→ UDP→ UTP→ UDP-glucose (black arrows), corresponding to the UMP branch of
the experimentally shown pathway (Figure 6.1).






D-glucose 1-phosphate UDP-glucoseR00289sucrose R00803
Figure 6.3: Pathway candidate to UDP-glucose from sucrose, CTP, orthophosphate and water.
R00803: sucrose:phosphate α-D-glucose-glucosyltransferase; R00289: UTP:α-D-glucose-glucose-
1-phosphate uridylyltransferase; R00568: CTP aminohydrolase. Black arrows: arcs used on the









Figure 6.4: Pathway candidate to UDP-glucose from D-glucose 6-phosphate, UMP and ATP.
R08639: α-D-glucose 1,6-phosphomutase; R00289: UTP:α-D-glucose-glucose-1-phosphate uridy-
lyltransferase; R00156: ATP:UDP phosphotransferase; R00158: ATP:UMP phosphotransferase.
Black arrows: arcs used on the linear path. Metabolite names in small script denote cofactors or
inorganic metabolites.
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6.3 Discussion
As the presented results show, the experimentally implemented pathway depicted in Figure
6.1 can be obtained by combining the linear paths of the pathway candidates shown in
Figures 6.3 and 6.4. The combination of multiple pathways is an interesting approach to
generate further pathway candidates for cases in which the desired pathway is not contained
in the path-finding results. It can be applied whenever reactions with multiple arcs such
as reaction R00289 in Figure 6.1 are included in a pathway. This reaction contains the
arcs D-glucose-1-phosphate - UDP-glucose and UTP - UDP-glucose and therefore allows the
combination of pathways were one of those arcs is active with pathways where the other arc
is active.
To explain why the tool did not propose the pathway from Figure 6.1 as a single pathway
candidate, the details of the path-finding algorithm have to be inspected in more detail. As
already described in Section 4.2 MILP, a pathway consists of the linear path and supplying
reactions. In the pathway candidate shown in Figure 6.4, the linear path is UMP→ UDP
→ UTP→ UDP-glucose (R00158→ R00156→ R00289). D-glucose 1-phosphate, which is
a required substrate for R00289, is not contained in the metabolite pool. It thus has to be
synthesized. In this pathway candidate, this is done by reaction -R08639 (the supplying
reaction) from D-glucose 6-phosphate. Reaction R00803, which is used in the experimentally
implemented pathway, is not found as an alternative since the combination of active arcs of
the path and the chosen reactions are not different and a full enumeration of the supplying
reactions in the MILP has not been implemented. Since for the optimization problem all
reactions are treated equally, the choice of supplying reactions is arbitrarily done by the
CPLEX solver. A means of influencing which supplying reactions the solver chooses for a
pathway candidate besides minimizing the number of supplying reactions has not been
included in the algorithm. A possible extension of the objective function of the MILP that
heuristically takes into account the ∆r G value of a reaction by preferring reactions with a








2 · |R|+ 1
|R|∑
i=1
(1+∆Gni) · zi (6.1)
∆Gni is the ∆r G of reaction i normalized by the maximum |∆r G| of all reactions in the
network reconstruction. This objective function minimizes the number of active reactions
and the ∆r G of the supplying reactions. Using this objective function in the path-finding, the







This study presents the findings of the work on the two main aims in the scope of cell-free
systems defined in Chapter 3 Aims and Scope. A comprehensive workflow for the directed
design of biosynthetic production pathways using cell-free systems and the planning of such
syntheses (Part II Path-Finding and Network Analysis for Multi-Enzyme Biocatalysis) has been
developed and discussed. Additionally, a method for the creation and characterization of
genome-scale metabolic network reconstructions for the planning of biosynthetic production
pathways (Part III Network Reconstructions for Cell-Free Systems) has been established.
7.1 Path-Finding and Ranking
The developed path-finding method presented in this work is suitable for finding synthesis
pathways in metabolic network reconstructions of cell-free systems. The MILP-based method
computes pathway candidates to a given target metabolite in a metabolite graph, in which the
metabolites are connected by arcs derived from biologically meaningful reaction pairs defined
in the KEGG RCLASS database. A pathway discovered by the method consists of two parts.
The first part is a sequence of metabolites connected by reactions starting with one of the
start metabolites and ending with the product. The second part is a minimal set of reactions
supplying substrates required by the pathway reactions that are not directly available in
the metabolite pool composed of start metabolites, cofactors and inorganic compounds.
The MILP is defined by constraints that take into account the network topology and the
stoichiometries of the underlying reactions to identify biologically meaningful pathway
candidates. The constraints of the MILP can be adapted freely to customize it for the task at
hand. The presented method stands in contrast to other methods that either only account
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for shortest paths in a graph between a given start and end node without taking into account
stoichiometry; or methods that depend on a steady state in the network, which is not the
case in cell-free systems.
To handle the large number of results in the broad solution space of a pathway search to a
target metabolite and to highlight the most meaningful candidates, the pathways generated
are ranked according to various different criteria. The criteria comprise metrics such as
pathway length, reaction thermodynamics, the number of heterologous enzymes in a given
host organism, cofactor requirement, or number of potential side reactions. However, these
criteria can be fully adapted and expanded, to take into account further aspects that might
be of importance for a given synthesis.
By means of the examples GPP, amygdalin, pyrrolysine and (S)-2-phenyloxirane it is shown
that the method proposes meaningful pathway candidates that can be used as a base for
further investigation to find the most promising synthesis pathway candidate. The synthesis
pathway for the multi-step synthesis of UDP-glucose from sucrose, UMP, ATP and phosphate
that was implemented in a recombinant, permeabilized E. coli strain (WEYLER et al., 2015)
(Chapter 6 Synthesis Paths for UDP-glucose) has also been recovered successfully.
Overall, the method presented in this work is a useful tool for the planning of biosynthetic
syntheses. The different steps of the path-finding and ranking workflow can be adapted to
meet the needs of a specific project at hand, which makes the method highly versatile and
suitable for a variety of problems.
7.2 Model Building and Analysis
A workflow for building and characterizing genome-scale metabolic network reconstructions
for the planning of biosynthetic production pathways has been developed. This workflow is
used for the reconstruction of networks from the KEGG databases COMPOUND, REACTION
and ENZYME. The large number of reactions in KEGG has to be filtered in order to include only
meaningful reactions into our model reconstructions. For the network models, only reactions
whose reactants have KEGG COMPOUND identifiers, integer stoichiometric coefficients, that
are not generic or contain generic reactants and that have reaction class annotations are
taken into account. Reactions satisfying these requirements are included in a pan-organism
network model. Additionally, models from nine specific organisms chosen for biotechnological
and scientific importance are compiled using the organism annotation for the genes of the
enzymes catalyzing the suitable reactions.
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The metabolites in the models are grouped into different categories, which are treated
differently in the path-finding algorithm. Potential start metabolites can be used as start
point for a pathway candidate. This is also true for basis metabolites, which constitute a
hand-curated subset of inexpensive and easily available metabolites. Cofactors and inorganic
metabolites are excluded from arcs, but are freely available as substrates for reactions in a
pathway. These sets constitute a metabolite pool of freely available metabolites.
For all models, all possible target metabolites are determined automatically and pathway
candidates for them are computed. The presented path-finding method yields meaningful
results in different kinds of networks and network sizes. A tool based on BFS to quickly predict
if a given target compound could potentially be produced in a given host organism has also
been implemented. The different properties of the network reconstructions, such as network
hubs and connected components are furthermore analyzed. These properties, together with
the target reachability analysis allow for a more in-depth analysis of the networks.

CHAPTER 8
Concluding Remarks and Outlook
In the following, the aspects that have not been already addressed fully in other parts of
this work are wrapped up and discussed. Furthermore, this chapter gives an outlook for
subsequent expansions of the presented algorithm and methods.
8.1 Network Reconstruction and Curation
The data used in this study for assembling network reconstructions following the workflow
presented in Chapter 2 Network Design is taken from KEGG. However, depending on the
aim of the study in which the network reconstruction is used, it can be fully adapted to the
needs by using any database or data source providing the necessary information (Section
2.1 Databases). In general, the quality of a network reconstruction depends heavily on the
quality of the data used. It is thus important to use high quality (curated) data sources
that contain as much information as needed to obtain network reconstructions that are as
comprehensive as possible.
Gap filling of the network reconstruction is a vital step for obtaining well-founded results with
respect to finding pathway candidates to a product. So in a further iteration of the network
reconstruction workflow, it would be beneficial to employ gap-filling strategies to obtain
even more comprehensive network reconstructions (Section 2.3 Network Reconstruction).
Almost 50% of the reaction entries in KEGG (version 65.0) are orphan reactions lacking
an associated protein sequence or enzyme (SOROKINA et al., 2014). While building the
organism-specific network model reconstructions it can be observed that only about 78 % of
the reactions from the pan-organism model have associated enzyme(s) (Figure 5.3). As in
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the presented filtering scheme enzyme associations are a requirement for associating the
respective reaction to an organism, a large part of the reactions in KEGG does not qualify for an
organism-specific model as these reactions do not have any enzymes associated. Associating
orphan reactions with enzymes could thus improve the quality of network reconstruction
models.
As discussed in Section 5.2 Model Building, the default parameters of eQuilibrator’s (FLAMHOLZ
et al., 2012) have been used for the computation of the ∆r G values. To determine reaction
reversibility, a ∆r G value of 15 kJ/mol was chosen empirically. However, the parameters
for the thermodynamics can be easily adapted if necessary, even individually for each reac-
tion. Additionally, the estimated values could easily be replaced by experimental values, if
available.
A meaningful expansion of the network reconstruction step would be to take into account
enzyme concentrations or kinetic parameters (SRINIVASAN et al., 2015).
8.2 Path-Finding
The presented path-finding method is highly customizable and can easily be adapted to the
respective requirements of the studies in which it is employed. There are numerous aspects
of the tool that can be tailored to the respective needs. One possibility is to customize the
MILP by adding, modifying or removing constraints. In this study, the MILP is applied on a
network representing cell free systems instead of a living organism, so it is not assumed that
any metabolite is in steady-state in the network. However, adding the constraint (8.1) (the
mathematical notation following Section 4.2 MILP), would be applicable in the case where
the objective is to find synthesis paths in living cells. Given a set of internal metabolites I ,
the constraint ensures that these metabolites are balanced.
|R|∑
r=1
Smr vr = 0, ∀m ∈ I (8.1)
The result of the path-finding heavily depends on the choice of arcs. The reason for choosing
reaction pairs as basis for the arcs in this study has been discussed in Appendix Section B.2.
However, the method of extracting arcs from reactions is totally customizable and can be
fully adapted.
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It is also possible to completely customize the different metabolite lists. The start and basis
metabolites can be specified depending on the specified target or on the availability of certain
substrates. The list of cofactors and inorganic compounds is also fully customizable to account
for a specific kind of medium composition.
The objective function of the MILP presented in Section 6 that minimizes the number of
active reactions as well as the ∆r G of the supplying reactions is only one possible extension
of the path-finding algorithm. A further aspect that could be taken into account are the costs
of substrates that are needed for the supplying reactions.
A further extension of the MILP would be to investigate if a full enumeration of the supplying
reactions is possible (and meaningful) to deliver even more pathway candidates.
8.3 Ranking
All ranking criteria can be fully adapted and extended. It is possible to define all kinds of
ranking criteria based on the respective synthesis. The order of the ranking criteria can be
rearranged to change the impact of a specific criterion. Additionally, more ranking criteria
can be incorporated. A practical and meaningful extension would be to incorporate the
prices of the substrates. This was not possible during the study due to the lack of a readily
available method for automatically extracting prices for purchasable substrates. Given such
a price list, it would be possible to rank the pathway candidates based on the prices of their
required substrates. One could even tailor the list of starting metabolites depending on
the availability of certain substrates and exclude those that are not purchasable. A step
forward to this ranking criterion would be to categorize the substrates into categories such
as inexpensive/expensive and prefer pathway candidates that contain more inexpensive
substrates.
8.4 Further Aspects
In Chapter 4 Network Design and Analysis for Multi-Enzyme Biocatalysis the detection of
potential side reaction for a given pathway candidate as an additional ranking criterion is
presented. However, this criterion can only consider reactions already incorporated in KEGG.
In most cases, KEGG only contains the main reaction(s) for a specific enzyme. It would
thus be a meaningful addition to take into account further data sources and tools which
contain information on side reactions of enzymes, such as BRENDA (JESKE et al., 2018),
MINE (JEFFRYES et al., 2015) or ATLAS of Biochemistry (HADADI et al., 2016).
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A further interesting extension would be to account for cofactor regeneration systems. This
could for example be done by taking into account cofactor usage and adding reactions that
regenerate cofactors to a pathway candidate.
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FADH2 reduced flavin adenine dinucleotide






BioPax Biological Pathway Exchange
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CMP Cytidine-5’-monophosphate











KEGG Kyoto Encyclopedia of Genes and Genomes
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in vivo refers to an experiment or a synthesis performed in whole, living organisms or cells
MATLAB MATrix LABoratory; Programming language and numerical computation environ-
ment by MathWorks.
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A Appendix Network Design and Analysis for Multi-Enzyme
Biocatalysis
The following chapter is based on the the supplementary material of the research ar-




Pathway Candidate: Mevalonate Pathway
Table A.1: Ranking of pathway candidate to geranyl pyrophosphate: mevalonate pathway
criterion value
number of active reactions: 8
starts with basic: False
reactions w/o dG: 0
sum (dG + |dG|): 0
dG: -2.154517e+02
number of heterologous enzymes: 5
number of cofactors: 8
number of side reactions: 11










































R01121 : ATP:(R)-5-diphosphomevalonate carboxy-lyase (adding ATP -6.741552e+01







1 C00129 Isopentenyl diphosphate
1 C00011 CO2
R01123 : Isopentenyl-diphosphate delta3-delta2-isomerase -4.902559e+00
substrates:
1 C00129 Isopentenyl diphosphate
products:




1 C00235 Dimethylallyl diphosphate
1 C00129 Isopentenyl diphosphate
products:
1 C00013 Diphosphate
1 C00341 Geranyl diphosphate
Overall Balance
Table A.2 shows the overall balance of the pathway candidate representing the mevalonate
pathway.
Side Reactions




1 C00575 3',5'-Cyclic AMP
1 C00013 Diphosphate
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R02003 : Geranyl-diphosphate:isopentenyl-diphosphate geranyltrans-transferase
substrates:
1 C00341 Geranyl diphosphate
1 C00129 Isopentenyl diphosphate
products:
1 C00013 Diphosphate
1 C00448 trans,trans-Farnesyl diphosphate
-R00127 : -ATP:AMP phosphotransferase
substrates:
2 C00008 ADP

















1 C00455 Nicotinamide D-ribonucleotide
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Pathway Candidate: Non-mevalonate Pathway
Table A.3: Ranking of pathway candidate to geranyl pyrophosphate: non-mevalonate pathway
criterion value
number of active reactions: 9
starts with basic: False
reactions w/o dG: 2
sum (dG + |dG|): 0
dG: -1.998150e+02
number of heterologous enzymes: 0
number of cofactors: 3
number of side reactions: 24




1 C00118 D-Glyceraldehyde 3-phosphate
products:
1 C11437 1-Deoxy-D-xylulose 5-phosphate
1 C00011 CO2
R05688 : 1-Deoxy-D-xylulose-5-phosphate isomeroreductase -2.321112e+01
substrates:




1 C11434 2-C-Methyl-D-erythritol 4-phosphate
1 C00006 NADP+
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R05633 : CTP: 2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase -4.729713
e+00
substrates:
1 C11434 2-C-Methyl-D-erythritol 4-phosphate
1 C00063 CTP
products:
1 C11435 4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol
1 C00013 Diphosphate
R05634 : ATP:4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol 2-
phosphotransferase -5.273891e+00
substrates:
1 C11435 4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol
1 C00002 ATP
products:
1 C11436 2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol
1 C00008 ADP
R05637 : 2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol CMP-lyase (
cyclizing) 0
substrates:
1 C11436 2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol
products:
1 C11453 2-C-Methyl-D-erythritol 2,4-cyclodiphosphate
1 C00055 CMP
R08689 : (E)-4-hydroxy-3-methylbut-2-en-1-yl-diphosphate:oxidized ferredoxin
oxidoreductase (hydrating) 0
substrates:
1 C11453 2-C-Methyl-D-erythritol 2,4-cyclodiphosphate
2 C00138 Reduced ferredoxin
products:
1 C11811 1-Hydroxy-2-methyl-2-butenyl 4-diphosphate
1 C00001 H2O
2 C00139 Oxidized ferredoxin
R08210 : dimethylallyl diphosphate:ferredoxin oxidoreductase -6.639758e+01
substrates:
1 C11811 1-Hydroxy-2-methyl-2-butenyl 4-diphosphate
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2 C00138 Reduced ferredoxin
2 C00080 H+
products:
1 C00235 Dimethylallyl diphosphate





1 C00235 Dimethylallyl diphosphate
1 C00129 Isopentenyl diphosphate
products:
1 C00013 Diphosphate
1 C00341 Geranyl diphosphate
----------
-R01123 : -Isopentenyl-diphosphate delta3-delta2-isomerase 0
substrates:
1 C00235 Dimethylallyl diphosphate
products:
1 C00129 Isopentenyl diphosphate
Overall Balance
Table A.4 shows the overall balance of the pathway candidate representing the non-mevalonate
pathway.
Side Reactions






R00086 : ATP phosphohydrolase
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1 C00575 3,5-Cyclic AMP
1 C00013 Diphosphate
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1 C00112 CDP
1 C00074 Phosphoenolpyruvate
R01015 : D-glyceraldehyde-3-phosphate aldose-ketose-isomerase
substrates:
1 C00118 D-Glyceraldehyde 3-phosphate
products:
1 C00111 Glycerone phosphate
R01123 : Isopentenyl-diphosphate delta3-delta2-isomerase
substrates:
1 C00129 Isopentenyl diphosphate
products:
1 C00235 Dimethylallyl diphosphate
R01195 : Ferredoxin:NADP+ oxidoreductase
substrates:




1 C00005 Oxidized ferredoxin
2 C00139 NADPH
R02003 : Geranyl-diphosphate:isopentenyl-diphosphate geranyltrans-transferase
substrates:
1 C00341 Geranyl diphosphate
1 C00129 Isopentenyl diphosphate
products:
1 C00013 Diphosphate
1 C00448 trans,trans-Farnesyl diphosphate
R05884 : isopentenyl-diphosphate:ferredoxin oxidoreductase
substrates:
1 C11811 1-Hydroxy-2-methyl-2-butenyl 4-diphosphate
2 C00138 Reduced ferredoxin
2 C00080 H+
products:
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1 C00129 Isopentenyl diphosphate
1 C00001 Oxidized ferredoxin
2 C00139 H2O


















1 C01353 Carbonic acid









-R00513 : -ATP:cytidine 5-phosphotransferase
substrates:
1 C00008 ADP









1 C00118 D-Glyceraldehyde 3-phosphate
products:
1 C01286 2-Dehydro-3-deoxy-6-phospho-D-galactonate
-R05605 : -2-dehydro-3-deoxy-6-phospho-D-gluconate D-glyceraldehyde-3-phosphate-
lyase (pyruvate-forming)
substrates:












Pathway Candidate: Starting From Sucrose
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Table A.5: Ranking of pathway candidate to amygdalin starting from sucrose
criterion value
number of active reactions: 4
starts with basic: True
reactions w/o dG: 0
sum (dG + |dG|): 9.763018e-02
dG: -4.130443e+01
number of heterologous enzymes: 2
number of cofactors: 1
number of side reactions: 4
1 C00095 D-Fructose
1 C00103 D-Glucose 1-phosphate
R00289 : UTP:alpha-D-glucose-1-phosphate uridylyltransferase -8.295754e+00
substrates:
1 C00075 UTP
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Thermodynamic Profile
Figure A.1 shows the thermodynamic profile for the pathway candidate for the synthesis of
amygdalin from α-D-glucose 6-phosphate.














Figure A.1: Thermodynamic profile for the pathway candidate of the synthesis of amygdalin
from sucrose.
Overall Balance
Table A.6 shows the overall balance of the pathway candidate for the synthesis of amygdalin
from sucrose.
Side Reactions
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Table A.6: Overall balance of the pathway candidate to amygdalin starting from sucrose
R00803 R00289 R10638 R10639 overall
sucrose -1 0 0 0 -1
orthophosphate -1 0 0 0 -1
D-fructose 1 0 0 0 1
D-glucose 1-phosphate 1 -1 0 0 0
UTP 0 -1 0 0 -1
diphosphate 0 1 0 0 1
UDP-glucose 0 1 -1 -1 -1
mandelonitrile 0 0 -1 0 -1
prunasin 0 0 0 -1 -1
UDP 0 0 1 1 2
amygdalin 0 0 0 1 1





R00959 : alpha-D-Glucose 1-phosphate 1,6-phosphomutase
substrates:
1 C00103 D-Glucose 1-phosphate
products:
1 C00668 alpha-D-Glucose 6-phosphate
R08639 : alpha-D-glucose 1,6-phosphomutase
substrates:
1 C00103 D-Glucose 1-phosphate
products:
1 C00092 D-Glucose 6-phosphate
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Pathway Candidate: Starting From α-d-glucose 6-phosphate
Table A.7: Ranking of pathway candidate to amygdalin from α-D-glucose 6-phosphate
criterion value
number of active reactions: 4
starts with basic: False
reactions w/o dG: 0
sum (dG + |dG|): 2.070859e+00
dG: -3.202206e+01
number of heterologous enzymes: 2
number of cofactors: 1
number of side reactions: 5
-R00959 : -alpha-D-Glucose 1-phosphate 1,6-phosphomutase 4.881509e-02
substrates:
1 C00668 alpha-D-Glucose 6-phosphate
products:
1 C00103 D-Glucose 1-phosphate
R00289 : UTP:alpha-D-glucose-1-phosphate uridylyltransferase -1.412458e+01
substrates:
1 C00075 UTP





















Figure A.2 shows the thermodynamic profile for the pathway candidate for the synthesis of
amygdalin from α-D-glucose 6-phosphate.












Figure A.2: Thermodynamic profile for the pathway candidate of the synthesis of amygdalin
from α-D-glucose 6-phosphate.
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Overall Balance
Table A.8 shows the overall balance of the pathway candidate for the synthesis of amygdalin
from α-D-glucose 6-phosphate.
Table A.8: Overall balance of the pathway candidate to amygdalin starting from α-D-glucose
6-phosphate
R00289 R10638 R10639 -R00959 overall
α-D-glucose 6-phosphate 0 0 0 -1 -1
D-glucose 1-phosphate -1 0 0 1 0
UTP -1 0 0 0 -1
UDP 0 1 1 0 2
diphosphate 1 0 0 0 0
UDP-glucose 1 -1 -1 0 -1
mandelonitrile 0 -1 0 0 -1
prunasin 0 1 -1 0 0
amygdalin 0 0 1 0 1
Side Reactions





R00959 : alpha-D-Glucose 1-phosphate 1,6-phosphomutase
substrates:
1 C00103 D-Glucose 1-phosphate
products:
1 C00668 alpha-D-Glucose 6-phosphate
R02737 : UDPglucose:D-glucose-6-phosphate 1-alpha-D-glucosyltransferase
substrates:
1 C00029 UDP-glucose
1 C00668 alpha-D-Glucose 6-phosphate
products:
1 C00015 UDP
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1 C00689 alpha,alpha'-Trehalose 6-phosphate
R02740 : alpha-D-Glucose 6-phosphate ketol-isomerase
substrates:
1 C00668 alpha-D-Glucose 6-phosphate
products:
1 C05345 beta-D-Fructose 6-phosphate
R08639 : alpha-D-glucose 1,6-phosphomutase
substrates:
1 C00103 D-Glucose 1-phosphate
products:
1 C00092 D-Glucose 6-phosphate
Pyrrolysine
Pathway Candidate
Table A.9: Ranking of pathway candidate to pyrrolysine.
criterion value
number of active reactions: 4
starts with basic: True
reactions w/o dG: 4
sum (dG + |dG|): 0
dG: 0
number of heterologous enzymes: 4
number of cofactors: 2
number of side reactions: 9






























Table A.10 shows the overall balance of the pathway candidate for the synthesis of pyrrolysine
from L-Lysine.
Side Reactions
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Table A.10: Overall balance of the pathway candidate to pyrrolysine.
R10010 R10011 R10012 R10013 overall
L-lysine -1 -1 0 0 -2
(2R,3R)-3-methylornithine 1 -1 0 0 0
ATP 0 -1 0 0 -1
(2R,3R)-3-methylornithinyl-N6-
lysine
0 1 -1 0 0
products of ATP breakdown 0 1 0 0 1
NAD+ 0 0 -1 0 -1
H2O 0 0 -1 0 1
(2R,3R)-3-methylglutamyl-5-
semialdehyde-N6-lysine
0 0 1 -1 0
NADH 0 0 1 0 1
L-pyrrolysine 0 0 0 1 1
1 C00009 Orthophosphate











1 C00575 3',5'-Cyclic AMP
1 C00013 Diphosphate






1 C00455 Nicotinamide D-ribonucleotide
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R11104 : NADH phosphohydrolase
substrates:
1 C00004 NADH







Table A.11: Ranking of pathway candidate to (S)-2-phenyloxirane
criterion value
number of active reactions: 4
starts with basic: False
reactions w/o dG: 1
sum (dG + |dG|): 2.081496e+01
dG: -1.728943e+01
number of heterologous enzymes: 4
number of cofactors: 3
number of side reactions: 11
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1 C00010 CoA

















Table A.12 shows the overall balance of the pathway candidate to (S)-2-phenyloxirane.
Side Reactions
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R00089 : ATP diphosphate-lyase (cyclizing
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Table A.12: Overall balance of the pathway candidate to (S)-2-phenyloxirane.
R02506 -R02255 R11070 R05488 overall
cinnamaldehyde -1 0 0 0 -1
CoA -1 1 0 0 0
NADP+ -1 0 0 0 -1
cinnamoyl-CoA 1 -1 0 0 0
NADPH 1 0 0 0 1
H+ 1 0 0 0 1
AMP 0 -1 0 0 -1
diphosphate 0 -1 0 0 -1
ATP 0 1 0 0 1
trans-cinnamate 0 1 -1 0 0
styrene 0 0 1 -1 0
CO2 0 0 0 1 1
FADH2 0 0 0 -1 -1
oxygen 0 0 0 -1 -1
(S)-2-phenyloxirane 0 0 0 1 1
FAD 0 0 0 1 1




1 C00575 3',5'-Cyclic AMP
1 C00013 Diphosphate
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1 C00117 D-Ribose 5-phosphate













1 C00119 5-Phospho-alpha-D-ribose 1-diphosphate





1 C01353 Carbonic acid

















We generated 1645 pathway candidates. Figure A.4(a) shows the number of pathway
candidates over time. The computation time for the individual pathway candidates is shown
in Figure A.4(b).
computation time in seconds x 104


























(a) Number of pathway candidates over time
for geranyl pyrophosphate.
pathway candidate



























(b) Computation time for individual pathway
candidates for geranyl pyrophosphate.
Figure A.4: Geranyl pyrophosphate.
Amygdalin
We generated 100 pathway candidates. Figure A.5(a) shows the number of pathway candi-
dates over time. The computation time for the individual pathway candidates is shown in
Figure A.5(b).
Pyrrolysine
5 pathway candidates were generated. Figure A.6(a) shows the number of pathway candi-
dates over time. The computation time for the individual pathway candidates is shown in
Figure A.6(b).
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time in seconds


























(a) Computation time for individual pathway
candidates for amygdalin.
pathway candidate

























(b) Number of pathway candidates over time
for amygdalin.
Figure A.5: Amygdalin.




























(a) Number of pathway candidates over time
for pyrrolysine.





























11 pathway candidates were generated. Figure A.7(a) shows the number of pathway candi-
dates over time. The computation time for the individual pathway candidates is shown in
Figure A.7(b).
Remarks
We showed the number of pathway candidates over time empirically for the example pathway
searches we presented in Section 4.3 Results. For a typical pathway search, the computation
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time in seconds























(a) Number of pathway candidates over time
for (S)-2-phenyloxirane.
pathway candidate

























(b) Computation time for individual pathway
candidates for (S)-2-phenyloxirane.
Figure A.7: (S)-2-phenyloxirane.
time was in the range of minutes for the first 100 pathway candidates. For all examples, the
trend shows that the solver takes more time with each solution, due to the fact that for each
additional solution, the number of constraint and variables in the MILP grows.
B Appendix In-depth characterization of genome-scale network
reconstructions for the in vitro synthesis in cell-free systems
The following chapter is based on the the supplementary material of the research article
(SCHUH et al., 2019) (Chapter 5 Network Reconstructions for Cell-Free Systems).
B.1 MILP
The MILP presented below identifies pathway candidates for a given target T from a given
list of possible starting metabolites.
|M |∑
i=1
uiP = 1 (B.1)
|M |∑
j=1






ul j l ∈ S; l 6= T (B.3)
|M |∑
i=1






uk j k ∈ M \ S; k 6= T (B.5)
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|M |∑
i=1
uik ≤ 1, k = 1, . . . , |M | (B.6)
Constraints (B.1) to (B.6) ensure that a solution contains a connected simple path from a
start node of the set of designated start nodes to the given end note T.
|R|∑
r=1
Smr vr ≥ 0, ∀m ∈ E, m /∈ Em (B.7)
|R|∑
r=1
STr vr ≥ 1, (B.8)
zr ≤ vr , r = 1, . . . , R (B.9)
and vr ≤ Max · zr , r = 1, . . . ,R (B.10)
zλ + zµ ≤ 1 (B.11)
∀(λ,µ) ∈ B = {(λ,µ)|λ and µ are reverse}
|R|∑
r=1
di jr · zr ≥ ui j i = 1, . . . ,|M |; j = 1, . . . ,|M |; i 6= j (B.12)
The constraint formulated in equation (B.13) prevents the use of a a reaction in the pathway
that consumes the target T. The set RT is the set of reactions that consume the target and
thus have a negative stoichiometric coefficient.∑
r∈RT
vrSr ≥ 0, RT = {r|STr < 0} (B.13)
Constraints (B.7) to (B.13) define a valid flux distribution for the pathway ensuring that the
found path is feasible.
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The MILP consisting of equations (B.1) to (B.14) provides a pathway candidate given by
a sequence of arcs (i.e. the values of ui j) and the active reactions (the values of zr). The
objective function guarantees a connected and cycle-free linear path with a minimal number
of supplying reactions.





















i j )ui j + sk′ |M |







i j ui j −
|M |∑
i







i j − 1 (B.17)
|R|∑
i
Z ′li zi + sk|R| ≤ ml − 1+ |R| (B.18)
An in-depth discussion of each constraint of the MILP can be found in Section 4.2 Mathemat-
ical Model.
B.2 Arc Graph Properties
Node Degree Distributions
Figure B.1 shows the node degree distributions of the arc graphs of the different organism
network reconstructions.
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Figure B.1: Total node degree distributions of the different organism networks.
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Figure B.1: Total node degree distributions of the different organism networks (continued).
Hubs
Tables B.1 to B.10 list the hubs with the top 5 occurrences of each network.
Table B.1: Hubs in kegg
count KEGG ID name
167 C00022 pyruvate





Table B.11 lists the sizes of the arc graphs together with the average node degrees (sum of
ingoing and outgoing arcs) and the standard deviation σ.
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Table B.2: Hubs in cge





18 C05345 β-D-fructose 6-phosphate
18 C00020 AMP
18 C00065 L-serine
Table B.3: Hubs in eco
count KEGG ID name
60 C00022 pyruvate
33 C00024 acetyl-CoA
30 C00111 glycerone phosphate
24 C00025 L-glutamate
24 C00118 D-glyceraldehyde 3-phosphate
Table B.4: Hubs in vna




24 C00111 glycerone phosphate
20 C00118 D-glyceraldehyde 3-phosphate
Table B.5: Hubs in ppun




19 C00118 D-glyceraldehyde 3-phosphate
17 C00109 2-oxobutanoate
Table B.6: Hubs in mxa




19 C00118 D-glyceraldehyde 3-phosphate
18 C00037 L-serine
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Table B.7: Hubs in sce




18 C05345 β-D-fructose 6-phosphate
17 C00118 D-glyceraldehyde 3-phosphate
17 C00065 L-Serine
Table B.8: Hubs in spo
count KEGG ID name
31 C00022 pyruvate
22 C00025 L-glutamate
18 C05345 β-D-fructose 6-phosphate
17 C00118 D-glyceraldehyde 3-phosphate
16 C00020 AMP
16 C00026 2-oxoglutarate
Table B.9: Hubs in cgb
count KEGG ID name
31 C00022 pyruvate
23 C00025 L-glutamate
19 C00118 D-glyceraldehyde 3-phosphate
14 C00024 acetyl-CoA
13 C00111 glycerone phosphate
Table B.10: Hubs in mpe
count KEGG ID name
13 C00111 glycerone phosphate
13 C00118 D-glyceraldehyde 3-phosphate
9 C00085 D-fructose 6-phosphate
9 C05345 β-D-fructose 6-phosphate
8 C03794 N6-(1,2-dicarboxyethyl)-AMP
7 C05378 β-D-fructose 1,6-bisphosphate
7 C00147 adenine
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Table B.11: Number of metabolites, arcs and average node degrees (sum of ingoing and outgoing
arcs) and their standard deviation σ of each model.
model metabolites with arcs arcs average node degree σ
kegg 6246 10291 3.3 4.45
cge 1395 2056 2.95 2.64
eco 1106 1736 3.14 3.28
vna 1093 1663 3.04 3.04
ppun 1154 1683 2.92 2.9
mxa 997 1424 2.86 2.58
sce 954 1303 2.73 2.55
spo 840 1187 2.83 2.54
cgb 768 1093 2.85 2.51
mpe 263 312 2.37 1.83
One can observe that the average node degrees are similar for all models, regardless of the
arc graph size. The higher average node degree in kegg could be caused by the fact that this
model consists of all reactions fulfilling the criteria discussed in Section 5.2, whereas in the
organism models the reactions are additionally selected by organism annotation, which may
introduce a bias.
Arc Graph Creation
As explained in Section 5.2 Model Building, the basis of the arc graph is the set of reactant
pairs from KEGG RCLASS for each reaction without those containing cofactors or inorganic
metabolites. In the following, we will discuss the reasoning behind that choice. To do
so, we built four different arc graphs for each model, listed in Table B.12. Arc graph 1
Table B.12: Setup for the four different arc graphs in discussion. In the second column, the ’+’
marks that the arcs in the respective arc graph are derived from the KEGG RCLASS entries of the
reactions in the model, the ’-’ denotes that the cross product of all substrates and products of the
reactions is used. In the third column, a ’+’ means that arcs containing cofactors and inorganic
compounds are included, a ’-’ means that such arcs are excluded.
arc graph RCLASS cofactors/inorganics number arcs number vertices
1 + - 10291 6246
2 + + 10697 6329
3 - - 15118 6366
4 - + 25231 6467
is built as described in Section 5.2 Model Building and comprises arcs derived from the
RCLASS reaction pairs (i.e. reaction pairs based on chemical structure patterns), without arcs
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containing cofactors or inorganic metabolites. This arc graph was applied in our path-finding
calculations. This setup allows synthesis of the predicted compounds in the network, as
demonstrated by the results presented and discussed in Section 5.3 Reachability Analysis. In
arc graph 2, we additionally included arcs involving cofactors and inorganic metabolites. As
KEGG RCLASS predominantly contains relevant arcs, arcs involving cofactors and inorganic
metabolites are not normally included in the first place. For this reason the number of arcs
does not significantly increase from arc graph 1 to 2. In arc graph 3 all possible substrate-
reaction pairs are used, but arcs involving cofactors are not, whereas arc graph 4 consists of
all substrate-reaction pairs. For each of those arc graphs we investigated the top 10 hubs
(based on occurrence), which are listed for the pan-organism network kegg, exemplarily
in Tables B.13 to B.16. These tables show that those arc graphs which incorporate arcs
containing containing cofactors and inorganic metabolites (arc graphs 2 and 4) also have
such metabolites in their top 10 hubs. In the arcs derived from all substrate-reaction pairs,
8 out of 10 hubs are cofactors or inorganic metabolites. For the arcs derived from KEGG
RCLASS, only one of the ten hubs is a cofactor. It is thus reasonable to exclude cofactors and
inorganic metabolites from arcs, as already stated in Section 5.2 Model Building. Comparing
the arc graphs 1 and 3 (Tables B.13 and B.15), one can observe that arc graph 3, which is
based on all substrate-reaction pairs, contains mono- and diphosphates such as AMP or ADP.
These metabolites are not present in the top 10 hubs of arc graph 1, which is based on KEGG
RCLASS. Let us have a look at the example reaction given in equation 1.
S + ATP P + ADP + AMP {1}
Here, all substrate-reaction pairs are S-P, S-ADP, S-AMP, ATP-P, ATP-ADP, ATP-AMP. In
RCLASS most likely only the S-P arc will appear. Arc graph 3 uses S-P, S-ADP, S-AMP.
In most cases the arcs S-ADP and S-AMP are not meaningful connections, however. The
additional arcs in arc graph 3 predominantly consist of this kind of nonsensical arcs. It is
thus reasonable to derive the arcs from KEGG RCLASS and exclude arcs with cofactors and
inorganic metabolites.
Target Statistics
Table B.17 lists the numbers used for the analysis of the target search in the different organism
models in Figure 5.6.
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Table B.13: Top 10 hubs for arc graph 1 of Table B.12 based on KEGG RCLASS without arcs
containing cofactors and inorganic metabolites. The first column gives the number of occurrences,
the second column the KEGG COMPOUND id and the last column the name of the metabolite.
count KEGG id name
167 C00022 pyruvate









Table B.14: Top 10 hubs for arc graph 2 of Table B.12 based on KEGG RCLASS including arcs
containing cofactors or inorganic metabolites. The first column gives the number of occurrences,
the second column the KEGG COMPOUND id and the last column the name of the metabolite.
KEGG ids in bold are cofactors or inorganic metabolites.
count KEGG ID name
167 C00022 pyruvate
147 C00010 CoA
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Table B.15: Top 10 hubs for arc graph 3 of Table B.12 based on all substrate-reaction pairs
without arcs containing cofactors and inorganic metabolites. The first column gives the number
of occurrences, the second column the KEGG COMPOUND id and the last column the name of
the metabolite.











Table B.16: Top 10 hubs for arc graph 4 of Table B.12 based on all substrate-reaction pairs
including arcs containing cofactors or inorganic metabolites. The first column gives the number
of occurrences, the second column the KEGG COMPOUND id and the last column the name of
the metabolite. KEGG ids in bold are cofactors or inorganic metabolites.
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Table B.17: Raw data for plot in Figure 5.6. found and not predicted: targets for which a target
candidate has been found by our method, but that have not been predicted as feasible; found
and predicted: targets for which a target candidate has been found by our method; not found
(connectivity): targets for which a candidate has not been found due to the absence of an arc
path from any start metabolite to the target; not found (feasibility): targets for which a candidate
has not been found due to the lack of a feasible reaction that produces the target; not found
(feasibility): targets for which a candidate has not been found due to other reasons that are
discussed in Section 5.3 Reachability Analysis.
kegg cge eco vna ppun mxa sce spo cgb mpe
found and not pre-
dicted
99 9 15 1 0 2 4 0 11 0
found and predicted 2294 317 335 315 287 250 213 186 185 48
not found (connectiv-
ity - satellite compo-
nents)
1342 534 275 291 291 313 354 301 242 87
not found (connectiv-
ity - components with
start metabolites)
1082 157 184 177 231 144 91 72 95 27
not found (feasibil-
ity)
593 95 53 68 87 52 37 63 50 14
not found (other) 31 16 16 13 6 16 14 15 15 8
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Arc Graph Maps
Figure B.2 shows the arc graphs of the different organism networks. The components colored
in red are components containing potential start metabolites. Components in blue are
components without start metabolites.
(a) cge (b) eco
(c) vna (d) cgb
Figure B.2: Arc graphs of the different organism networks. Red: components containing
potential start metabolite; blue: satellite components without start metabolites.
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(e) ppun (f) mxa
(g) mpe (h) spo
(i) sce
Figure B.2: Arc graphs of the different organism networks (continued). Red: components
containing potential start metabolite; blue: satellite components without start metabolites.
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Arc Graph Component Histograms
Figure B.3 shows the arc graph component histograms of the different organism networks.















































































































































Figure B.3: Arc graph component histograms of the different organism networks.
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Figure B.3: Arc graph component histograms of the different organism networks (continued).
B.3 Components of the kegg Model
The components identified for the kegg model are listed in Table B.18. Component 1 contained
4612 compounds/metabolites representing the central metabolic network. In total there are
481 components with 6246 compounds/metabolites.
We investigated the identified components not directly connected to the main component
1 that contains 4612 compounds in the range from 5 to 33 compounds (Supplementary
Information 3 of (SCHUH et al., 2019)). These are in total 69 components representing 682
compounds/metabolites.
The members of the larger remaining components were of the families of
polyketides including macrolides (21/23, 28/19, 74/13, 63/10, 94/9, 115/9, 217/9, 152/6,
156/6, 112/5) - 10
flavonoids (15/33, 263/9, 210/7, 247/5) - 4
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Table B.18: Components in model kegg
























terpenoids (6/33, 7/31, 185/13, 38/7, 47/7, 245/6, 27/5, 223/5, 270/5) - 9
compounds with gonane type nucleus, also known as perhydrocyclopenta[a]phenanthrene
(e.g. steroids, cholic acid derivatives): (49/18, 5/17, 66/16, 73/7, 168/6, 31/5, 64/5) - 7
xenobiotic compounds, e.g. drugs (32/16, 108/14, 95/12, 109/12, 11/11, 18/11, 36/11,
70/9, 147/9, 206/9, 116/8, 23/7, 114/7, 194/5) - 14
other degradation pathways (30/12, 305/6) - 2
carbohydrate derived (4/24, 134/13, 68/9, 61/8, 180/6, 260/6, 83/5, 101/5, 149/5, 250/5)
- 10
fatty acids and lipids related (25/20, 44/5, 83/5, 101/5, 234/5, 318/5, 318/5) - 7
porphyrins (22/10, 62/6) - 2
amino acid derived (127/7, 69/6, 253/6, 9/5, 188/5) - 5
nucleotide derived (137/5) - 1
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B.4 Target Examples
UDP-glucose
















R04456 : R04456 5,10-methylenetetrahydromethanopterin:coenzyme-F420
oxidoreductase dG: 0
substrates:




1 C01080 Reduced coenzyme F420
1 C04330 5,10-Methenyltetrahydromethanopterin










R04464 : R04464 5,10-Methylenetetrahydromethanopterin:coenzyme-F420
oxidoreductase dG: -10.2
substrates:
1 C01080 Reduced coenzyme F420
1 C04377 5,10-Methylenetetrahydromethanopterin
products:
1 C00876 Coenzyme F420
1 C04488 5-Methyl-5,6,7,8-tetrahydromethanopterin
Biotin
Table B.19 lists reactions in the model that produce biotin but do not belong to the feasible
reactions in the network.
Table B.19: Reactions producing biotin that are not feasible in the network.
KEGG id reaction equation
R10127 biotin sulfoxide + NAD(P)H + H+ <=> biotin + NADP+ + H2O
-R01075 AMP + diphosphate + biotinyl-CoA <=> ATP + biotin + CoA
R01076 biotin amide + H2O <=> biotin + ammonia
R01077 biocytin + H2O <=> biotin + L-lysine
5’-methylthioadenosine
In the following, we list reactions in our model that produce 5’-methylthioadenosine and
belong to the feasible reactions in the network.
R10881
S-Adenosyl-L-methionine + Nocardicin G <=> 5'-Methylthioadenosine + Isonocardicin
C
no arc to target
R00180
S-Adenosyl-L-methionine <=> 5'-Methylthioadenosine + Homoserine lactone
no arc (cofactors)
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no arc to target
R11089
S-Adenosylmethioninamine + Norspermine <=> 5'-Methylthioadenosine +
Caldopentamine + H+
no pathway to substrate
-R01402
Adenine + S-Methyl-5-thio-D-ribose 1-phosphate <=> 5'-Methylthioadenosine +
Orthophosphate
no pathway to substrate
R08359
S-Adenosylmethioninamine + Cadaverine <=> 5'-Methylthioadenosine +
Aminopropylcadaverine
no pathway to substrate
R10338
S-Adenosylmethioninamine + Agmatine <=> 5'-Methylthioadenosine + N1-(3-
Aminopropyl)agmatine
no pathway to substrate
R01920
S-Adenosylmethioninamine + Putrescine <=> 5'-Methylthioadenosine + Spermidine
no pathway to substrate
R00175
S-Adenosyl-L-methionine + H2O <=> 5'-Methylthioadenosine + L-Homoserine
no arc (cofactors)
no arc to target
R11088
S-Adenosylmethioninamine + Norspermidine <=> 5'-Methylthioadenosine + Norspermine
+ H+
no pathway to substrate
R11154
2 S-Adenosylmethioninamine + Spermidine <=> 2 5'-Methylthioadenosine + N4-Bis(
aminopropyl)spermidine
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no pathway to substrate
R00179
S-Adenosyl-L-methionine <=> 1-Aminocyclopropane-1-carboxylate + 5'-
Methylthioadenosine
no arc (cofactors)
no arc to target
R11159
S-Adenosylmethioninamine + Spermidine <=> 5'-Methylthioadenosine + N4-
Aminopropylspermidine
no pathway to substrate
R03726
S-Adenosyl-L-methionine + N6-(Delta2-Isopentenyl)-adenine <=> 5'-
Methylthioadenosine + Discadenine
no arc to target
R03271
S-Adenosylmethioninamine + 1,3-Diaminopropane <=> 5'-Methylthioadenosine +
Norspermidine + H+
no pathway to substrate
R09531
S-Adenosylmethioninamine + Spermidine <=> 5'-Methylthioadenosine + Thermospermine
+ H+
no pathway to substrate
R03072
S-Adenosyl-L-methionine + Nocardicin E <=> 5'-Methylthioadenosine + Isonocardicin
A
no arc to target
R02869
S-Adenosylmethioninamine + Spermidine <=> 5'-Methylthioadenosine + Spermine
no pathway to substrate

C Appendix: Synthesis Paths for UDP-glucose
C.1 Pathway Candidates
sucrose -> UDP-glucose














Listing 1: Two-step pathway candidate to UDP-glucose from sucrose.
sucrose -> D-glucose 1-phosphate -> UDP-glucose





1 C00103 D-Glucose 1-phosphate
1 C00095 D-Fructose
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R00289 : R00289 UTP:alpha-D-glucose-1-phosphate uridylyltransferase dG: 0.929
substrates:





Listing 2: Pathway candidate to UDP-glucose from sucrose.














R00289 : R00289 UTP:alpha-D-glucose-1-phosphate uridylyltransferase dG: 0.929
substrates:
1 C00103 D-Glucose 1-phosphate
1 C00075 UTP




-R08639 : -R08639 alpha-D-glucose 1,6-phosphomutase dG: 7.392
substrates:
1 C00092 D-Glucose 6-phosphate
products:
1 C00103 D-Glucose 1-phosphate
Listing 3: Two-step pathway candidate to UDP-glucose from D-glucose 6-phosphate.

D Software
The software developed for this study is divided into two packages. The first package
comprises the tools for model building and model analysis. It is for the most part implemented
in Python 2.7; except the thermodynamics part, which is implemented in Python 3.6. The
implementation makes use of the external packages eQuilibrator (FLAMHOLZ et al., 2012),
graph-tool (PEIXOTO, 2014) and scipy (JONES et al., 2001). The second package is the
implementation of the path-finding algorithm and the pathway ranking and analysis, written
in MATLAB R2019a using IBM ILOG CPLEX as MILP solver.
D.1 Model Building
KEGG Parser
Parsers for extracting the data needed for model building from the raw KEGG entries from
KEGG COMPOUND, REACTION and ENZYME databases were implemented. All parsers
take a raw text entry as input and create an instance of the respective class containing the
relevant data for the model. The parsers can be found in the following scripts in MECATPy_-
KEGG: compound.py, reaction.py, enzyme.py, rclass.py, organism.py and pathway.py.
Parsing the raw data can be invoked by calling the script KEGGreader.py, which only needs
the respective filenames for the raw data and automatically creates Python pickles and
MATLAB dictionaries containing the parsed data.
Model
The network reconstruction models consist of the files listed in Table D.1, which are generated
by the script buildHostModels.py.
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Table D.1: Model files. model denotes the chosen model name (typically the KEGG organism
code).
filename description
cofactorsmodel.txt textfile containing the internal ids of the dedicated
cofactor and inorganic compounds
cofactors_namesmodel.txt textfile containing the KEGG ids, names and in-
ternal ids of the dedicated cofactor and inorganic
compounds
compoundsmodel.txt textfile containing the KEGG ids of all compounds
contained in the model
compounds_namesmodel.txt textfile containing the KEGG ids, names and inter-
nal ids of all compounds contained in the model
start_compoundsmodel.txt textfile containing the KEGG ids of the designated
start compounds
start_compounds_namesmodel.txt textfile containing the KEGG ids and names of the
designated start compounds
terminal_compoundsmodel.txt textfile containing the KEGG ids of the designated
basic compounds
terminal_compounds_namesmodel.txt textfile containing the KEGG ids and names of the
designated basic compounds
targets_organism.txt textfile containing the KEGG ids of the potential
target metabolites
targets_organism_names.txt textfile containing the KEGG ids and names of the
potential target metabolites
reactionsmodel.txt textfile containing the KEGG ids of all reactions con-
tained in the model. A ’-’ in front of the id denotes
that the reaction is reversed.
reactions_namesmodel.txt textfile containing the KEGG ids and names of all
reactions contained in the model
reversible_reactionsmodel.txt textfile containing the internal ids of the reversible
reactions (first column: reaction in KEGG direction,
second column: reaction in reversed direction)
reversible_reactions_namesmodel.txt textfile containing the KEGG ids of the reversible
reactions
non_enzymatic_reactionsmodel.txt textfile containing the KEGG ids of the non-
enzymatic reactions contained in the model. A ’-’ in
front of the id denotes that the reaction is reversed.
non_enzymatic_reactions_namesmodel.txt textfile containing the names of the non-enzymatic
reactions contained in the model
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Table D.1: Model files. model denotes the chosen model name (typically the KEGG organism
code) (continued).
filename description
thermodynamics.mat MATLAB map containing the thermodynamic data of all model
reactions
thermodynamicsmodel.map MATLAB struct containing the thermodynamic data of all model
reactions
RxR_keggmodel.txt textfile containing the arcs of the model given as pairs of internal
compound ids and the internal id of the respective reaction
RxR_kegg_namesmodel.txt textfile containing the arcs of the model given as pairs of KEGG
compound ids and the KEGG id of the respective reaction
arcs.mat MATLAB matrix containing the arcs of the model given as pairs of
internal compound ids
Smodel.mat MATLAB matrix with the stoichiometrix matrix. Row and column
indices correspond to the internal compound and reaction indices
model_model.pickle Python pickle file containing the Model class instance of the re-
spective model
feasible_reactions.txt textfile with the KEGG ids and equations of the feasible reactions




All necessary parameters for the path-finding tool can be given in a special input file, described
in Table D.2.
Table D.2: Parameters for the input file for the path-finding tool.
parameter type comment
DATA_PATH string path to the model data
GENERIC_METABOLITES text file contains generic metabolites
COFACTORS text file contains internal ids of cofactors
START_METABOLITES text file contains internal ids of start metabolites
BASIS_METABOLITES text file contains internal ids of basis metabolites
COMPOUNDS text file contains KEGG compound ids
REACTIONS text file contains KEGG reaction ids
COMPOUND_NAMES text file contains compound names
REACTION_NAMES text file contains reaction names
ARCS text file contains reaction pairs
STOICHIOMETRIC_MATRIX mat MATLAB formatted data containing the stoichiometric
matrix
REVERSIBLE_REACTIONS text file contains reversible reactions
KEGG_DATA_PATH string path to the KEGG data
REACTION_MAP mat MATLAB formatted data containing reaction data
COMPOUND_MAP mat MATLAB formatted data containing compound data
ENZYME_MAP mat MATLAB formatted data containing enzyme data
PATHWAY_MAP mat MATLAB formatted data containing pathway data
NON_ENZYMATIC_REACTIONS text file contains KEGG reaction ids of non-enzymatic reac-
tions
THERMODYNAMICS_MAP mat MATLAB formatted data containing thermodynamics
data
SBML_MODEL xml SBML file of model
REVERSIBILITIES_MAP mat MATLAB formatted data containing reaction reversibil-
ity information
HOST string KEGG organism code
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MILP Generation and Path-Finding
The basic script for the MILP generation and path-finding is fsr.m. It takes the filename of the
aforementioned input file. The basic MILP is set up with the script buildBasicProblem.m,
which is called automatically by fsr.m. The additional constraints to exclude pathways that
have already been found are added successively by the script findSynthesisRoutesAll.m
(also called automatically). There are two modes for path-finding. The default mode is
running the solver until no new pathway candidates can be found. The second one searches
for a user defined number of pathway candidates (at most). This can be set up in the script
findSynthesisRoutesAll.m. All pathway candidates are stored as MATLAB *.mat files in
the predefined folder under the respective target KEGG id and can be analyzed with the
ranking scripts described in the following section.
D.3 Analysis
The analysis encompasses different aspects. The first aspect is the ranking of the pathway
candidates for a given target. The second aspect is the analysis of the network reconstructions.
The last aspect is the analysis of the results of the pathway searches to all possible potential
targets of the network reconstructions.
Ranking
The ranking of pathway candidates for a specific target is done with the MATLAB script
writeTargets.m, which takes the filename of the configuration input file (Table D.2). The
script automatically calls the ranking scripts in the respective order, which can be varied
depending on how much weight a specific ranking function should have in the overall ranking.
In the default case, the order is as given in Table 4.1. The script also writes the pathway
candidates in a user-friendly manner which then can be assessed further.
Model Statistics
The Python script Statistics\ModelStatistics.py provides various model statistics. The
script writes general metabolite statistics including the number of metabolites, number of
external/generic metabolites, the size of the metabolite pool, number of start and basis
metabolites, as well as number of cofactors/inorganic metabolites. The reaction statistics
encompass the number of reactions in the model, number of unique reactions (without
reverse) and number of reversible reactions.
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There are analysis methods that explore properties of the arc graph of the network recon-
structions. For example, the script writes a list of the network metabolites together with
the component to which they belong to (Supplementary Information 3 of (SCHUH et al.,
2019)). This information can also be divided into lists containing all metabolites of the
main component and the metabolites of the other component. It also generates a histogram.
The degree distribution of the arc graphs can also be plotted. The script also performs the
reachability screening presented in Section 5.2. It also outputs the potential targets that are
reachable by BFS and those that are predicted to be feasible.
It is also possible to output the top n hubs in the network depending on the arc construction
method. If arcs with cofactors/inorganics are chosen, the script does also output which of
the top n hub metabolites belong to this group. Common hubs, which appear in the top n
hubs of each network model are also written.
Result Statistics
A prerequisite for the following scripts is that (i) for a given metabolic network reconstruction
the existence of a pathway candidate to each possible target is tested using the path-finding
method and (ii) the results have been processed with the MATLAB script writeTargets.m
to generate the file targets_overview.
The main part of the Python script OrganismResultStatistics.py is the generation of
the raw data and the plot shown in Table B.17 and Figure 5.6 based on the results of the
path-finding experiment. For each model, lists with the targets belonging to each category
are written. The script also determines which targets are common in all organism network
reconstructions (including the pan-organism model) and which ones are unique (excluding
the pan-organism network model).
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